GLP-1S Peptide

$53.00 – $123.00 Select options

GLP-1S Peptide

Price range: $53.00 through $123.00

Research-grade GLP-1S Peptide for laboratory investigation. For Research Use Only. Not for human use.

Size: No selection

More options

Clear

COA GLP-1S 5mg COA GLP-1S 10mg

For Research Use Only. Not for human use.

Overview

GLP-1S Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for GLP-1S Peptide

Work involving GLP-1S Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

Research-grade material intended for laboratory investigation only
Catalog labeling aligned with research procurement channels
Suitable for method development and comparative assay workflows
Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of GLP-1S Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source GLP-1S Peptide

Procurement and research teams often select this catalog item because it supports:

Clear research-use labeling for compliance-aligned purchasing
Consistent product identification across multi-lot studies
Fit for reference, screening, and mechanistic laboratory models
Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with GLP-1S Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using GLP-1S Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of GLP-1S Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 996 PubMed records. Displaying 10 per page.

Aronne LJ et al. (2025). Tirzepatide as Compared with Semaglutide for the investigation of metabolic research… [PMID: 40353578]
Laboratory literature summary: Tirzepatide as Compared with Semaglutide for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Smits MM et al. (2021). Laboratory profile of Semaglutide [PMID: 34305810]
Laboratory literature summary: laboratory profile of Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chao AM et al. (2023). Semaglutide for the investigation of metabolic research models [PMID: 34942372]
Laboratory literature summary: Semaglutide for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bliddal H et al. (2024). Once-Weekly Semaglutide in Persons with metabolic research models and Knee Osteoarthritis [PMID: 39476339]
Laboratory literature summary: Once-Weekly Semaglutide in Persons with metabolic research models and Knee Osteoarthritis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Weghuber D et al. (2022). Once-Weekly Semaglutide in Adolescents with metabolic research models [PMID: 36322838]
Laboratory literature summary: Once-Weekly Semaglutide in Adolescents with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lincoff AM et al. (2023). Laboratory research record on GLP-1S [PMID: 37952131]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Garvey WT et al. (2025). Laboratory research record on GLP-1S [PMID: 40544433]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Gabery S et al. (2020). Semaglutide lowers body weight in rodents via distributed neural pathways [PMID: 32213703]
Laboratory literature summary: Semaglutide lowers body weight in rodents via distributed neural pathways. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Singh G et al. (2022). Laboratory research record on GLP-1S [PMID: 34706925]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Knudsen LB et al. (2019). The Discovery and Development of Liraglutide and Semaglutide [PMID: 31031702]
Laboratory literature summary: The Discovery and Development of Liraglutide and Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang XD et al. (2024). Laboratory Pharmacokinetics of Semaglutide: A Systematic Review [PMID: 38952487]
Laboratory literature summary: laboratory Pharmacokinetics of Semaglutide: A Systematic Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Newsome PN et al. (2021). Laboratory research record on GLP-1S [PMID: 33185364]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Bergmann NC et al. (2023). Laboratory research record on GLP-1S [PMID: 36254579]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Suran M (2023). Laboratory research record on GLP-1S [PMID: 37099334]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dhillon S (2018). Semaglutide: First Global Approval [PMID: 29363040]
Laboratory literature summary: Semaglutide: First Global Approval. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2021). Laboratory research record on GLP-1S [PMID: 33830968]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Papakonstantinou I et al. (2024). Spotlight on the Mechanism of Action of Semaglutide [PMID: 39728000]
Laboratory literature summary: Spotlight on the Mechanism of Action of Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cai CX et al. (2025). Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy [PMID: 39976940]
Laboratory literature summary: Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pillarisetti L et al. (2025). Semaglutide: Double-edged Sword with Risks and Benefits [PMID: 39902055]
Laboratory literature summary: Semaglutide: Double-edged Sword with Risks and Benefits. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Niu S et al. (2022). Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model [PMID: 36568109]
Laboratory literature summary: Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tran MM et al. (2024). Dermatologic findings associated with semaglutide use: A scoping review [PMID: 38554940]
Laboratory literature summary: Dermatologic findings associated with semaglutide use: A scoping review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kolding L et al. (2025). Developmental research context Outcomes After Semaglutide Exposure [PMID: 40083043]
Laboratory literature summary: developmental research context Outcomes After Semaglutide Exposure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Meier JJ (2021). Laboratory research record on GLP-1S [PMID: 34248838]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (1994). Laboratory research record on GLP-1S [PMID: 38349989]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Maretty L et al. (2025). Proteomic changes upon investigation with semaglutide in individuals with metabolic… [PMID: 39753963]
Laboratory literature summary: Proteomic changes upon investigation with semaglutide in individuals with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Skov K et al. (2023). Semaglutide and developmental research context [PMID: 37688299]
Laboratory literature summary: Semaglutide and developmental research context. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Begum F et al. (2024). Semaglutide-associated kidney injury [PMID: 39258261]
Laboratory literature summary: Semaglutide-associated kidney injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bracchiglione J et al. (2025). Semaglutide for adults living with metabolic research models [PMID: 41161683]
Laboratory literature summary: Semaglutide for adults living with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cigrovski Berkovic M et al. (2023). Semaglutide-eye-catching results [PMID: 37122431]
Laboratory literature summary: Semaglutide-eye-catching results. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lähteenvuo M et al. (2025). Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder [PMID: 39535805]
Laboratory literature summary: Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mawardi HH et al. (2023). Semaglutide-associated hyposalivation: A report of case series [PMID: 38206684]
Laboratory literature summary: Semaglutide-associated hyposalivation: A report of case series. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
van Boxel EJ et al. (2024). Semaglutide investigation for children with metabolic research models: an… [PMID: 38471743]
Laboratory literature summary: Semaglutide investigation for children with metabolic research models: an observational study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Quddos F et al. (2023). Semaglutide and Tirzepatide reduce alcohol consumption in individuals with metabolic… [PMID: 38017205]
Laboratory literature summary: Semaglutide and Tirzepatide reduce alcohol consumption in individuals with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Haseeb M et al. (2024). Semaglutide vs Endoscopic Sleeve Gastroplasty for body-composition research [PMID: 38607627]
Laboratory literature summary: Semaglutide vs Endoscopic Sleeve Gastroplasty for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Greenway FL (2025). Semaglutide and Tirzepatide to Treat metabolic research models [PMID: 40601944]
Laboratory literature summary: Semaglutide and Tirzepatide to Treat metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Overgaard RV et al. (2019). Laboratory research record on GLP-1S [PMID: 30788808]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Propfe LE et al. (2026). Misrepresentation of semaglutide in social media [PMID: 40682686]
Laboratory literature summary: Misrepresentation of semaglutide in social media. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zarei M et al. (2025). The expanding role of semaglutide: beyond glycemic control [PMID: 40620322]
Laboratory literature summary: The expanding role of semaglutide: beyond glycemic control. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Humphrey CD et al. (2023). Laboratory research record on GLP-1S [PMID: 37541662]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (2012). Laboratory research record on GLP-1S [PMID: 31643889]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Ezhilarasan D (2025). Mechanism of Semaglutide in MASLD investigation: Where Is the Master Key? [PMID: 40538007]
Laboratory literature summary: Mechanism of Semaglutide in MASLD investigation: Where Is the Master Key?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2006). Laboratory research record on GLP-1S [PMID: 30000039]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Katz BJ et al. (2025). Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and… [PMID: 39883468]
Laboratory literature summary: Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kommu S et al. (2026). Laboratory research record on GLP-1S [PMID: 38753931]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Zhang X et al. (2021). Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes [PMID: 34260945]
Laboratory literature summary: Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kalsi H et al. (2025). Semaglutide-Induced Liver Injury [PMID: 40761336]
Laboratory literature summary: Semaglutide-Induced Liver Injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Salvador R et al. (2025). Semaglutide as a GLP-1 Agonist: A Breakthrough in metabolic research models investigation [PMID: 40143174]
Laboratory literature summary: Semaglutide as a GLP-1 Agonist: A Breakthrough in metabolic research models investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hughes S et al. (2020). Oral Semaglutide [PMID: 31975761]
Laboratory literature summary: Oral Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Simon TG (2025). Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis [PMID: 40466070]
Laboratory literature summary: Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stark J et al. (2025). Allodynia (skin tenderness) associated with semaglutide: A case series [PMID: 39862389]
Laboratory literature summary: Allodynia (skin tenderness) associated with semaglutide: A case series. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hwang YJ et al. (2024). Semaglutide in people with HIV-associated lipohypertrophy [PMID: 38964354]
Laboratory literature summary: Semaglutide in people with HIV-associated lipohypertrophy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bui V et al. (2018). Oral Semaglutide [PMID: 30364001]
Laboratory literature summary: Oral Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Okeke IG et al. (2024). Semaglutide-induced Hyperemesis Gravidarum [PMID: 38249445]
Laboratory literature summary: Semaglutide-induced Hyperemesis Gravidarum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bloomgarden ZT (2025). Semaglutide and the Retina [PMID: 40229996]
Laboratory literature summary: Semaglutide and the Retina. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nielsen MS et al. (2025). A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants [PMID: 39708086]
Laboratory literature summary: A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Haykal D (2025). Alopecia and Semaglutide: Connecting the Dots for research subjects laboratory profile [PMID: 40087997]
Laboratory literature summary: Alopecia and Semaglutide: Connecting the Dots for research subjects laboratory profile. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Holm SK et al. (2025). Sustained body-composition research With Combined LEAP2 and Semaglutide investigation… [PMID: 40590720]
Laboratory literature summary: Sustained body-composition research With Combined LEAP2 and Semaglutide investigation in Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Luo S et al. (2025). Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis [PMID: 40834308]
Laboratory literature summary: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Turunen AM et al. (2025). Semaglutide-Associated Gastric Pneumatosis [PMID: 39734391]
Laboratory literature summary: Semaglutide-Associated Gastric Pneumatosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Onggo S et al. (2025). Semaglutide-Mediated Lithium Toxicity [PMID: 40440507]
Laboratory literature summary: Semaglutide-Mediated Lithium Toxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim C et al. (2025). Uptake of and Disparities in Semaglutide and Tirzepatide Prescribing for metabolic… [PMID: 40299371]
Laboratory literature summary: Uptake of and Disparities in Semaglutide and Tirzepatide Prescribing for metabolic research models in the US. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Viard D et al. (2026). Semaglutide-Associated Hepatic Cytolysis [PMID: 40749812]
Laboratory literature summary: Semaglutide-Associated Hepatic Cytolysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Derington CG et al. (2025). Laboratory research record on GLP-1S [PMID: 41082229]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Marijic J et al. (2024). Semaglutide: A New Medical Swiss Army Knife? [PMID: 38246820]
Laboratory literature summary: Semaglutide: A New Medical Swiss Army Knife?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Manubolu VS et al. (2024). Laboratory research record on GLP-1S [PMID: 39168573]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Komé AM et al. (2025). Laboratory research record on GLP-1S [PMID: 39808463]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Burruss CP et al. (2021). Semaglutide-associated bullous pemphigoid [PMID: 34466645]
Laboratory literature summary: Semaglutide-associated bullous pemphigoid. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Muskiet MHA et al. (2025). Tirzepatide vs. Semaglutide for metabolic research models investigation [PMID: 41124642]
Laboratory literature summary: Tirzepatide vs. Semaglutide for metabolic research models investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Michel M et al. (2025). Semaglutide targets MASH molecular pathways beyond body-composition research [PMID: 40890553]
Laboratory literature summary: Semaglutide targets MASH molecular pathways beyond body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kalra S et al. (2026). Semaglutide: Real World Results, Realistic Recommendations [PMID: 42261005]
Laboratory literature summary: Semaglutide: Real World Results, Realistic Recommendations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Belmont-Rausch DM et al. (2026). Semaglutide attenuates neuroinflammation in research models mice [PMID: 42265098]
Laboratory literature summary: Semaglutide attenuates neuroinflammation in research models mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cai CX et al. (2025). Laboratory research record on GLP-1S [PMID: 41192935]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Wang W et al. (2025). Semaglutide Mitigates Ischemic Brain Injury by Inhibiting Ferroptosis via Modulation… [PMID: 40748430]
Laboratory literature summary: Semaglutide Mitigates Ischemic Brain Injury by Inhibiting Ferroptosis via Modulation of FoXO1 and DRP1 Pathways. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gras C et al. (2025). Semaglutide-induced Wernicke encephalopathy: a comprehensive analysis [PMID: 40908328]
Laboratory literature summary: Semaglutide-induced Wernicke encephalopathy: a comprehensive analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wasilewska B et al. (2025). Semaglutide – properties, action and chromatographic analysis [PMID: 40937273]
Laboratory literature summary: Semaglutide – properties, action and chromatographic analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu H et al. (2025). Laboratory research record on GLP-1S [PMID: 41370812]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Seiler T et al. (2026). Semaglutide-associated Twiddler syndrome [PMID: 42100587]
Laboratory literature summary: Semaglutide-associated Twiddler syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Muzurović E et al. (2025). Semaglutide and the retina: Weighing evidence against concern [PMID: 40769838]
Laboratory literature summary: Semaglutide and the retina: Weighing evidence against concern. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rozhdestvenskaya VA et al. (2025). [Effects of semaglutide on mental health] [PMID: 41051803]
Laboratory literature summary: [Effects of semaglutide on mental health]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2021). Laboratory research record on GLP-1S [PMID: 34543259]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dos Santos MCF et al. (2025). Oral Semaglutide and Cardiovascular Outcomes [PMID: 40802952]
Laboratory literature summary: Oral Semaglutide and Cardiovascular Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carris NW et al. (2022). Semaglutide for body-composition research [PMID: 34157885]
Laboratory literature summary: Semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Morton A et al. (2026). Developmental research context outcomes following first trimester exposure to semaglutide [PMID: 40487375]
Laboratory literature summary: developmental research context outcomes following first trimester exposure to semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Agarwal SM et al. (2025). Semaglutide for clozapine-studied research subjects with schizophrenia [PMID: 40506202]
Laboratory literature summary: Semaglutide for clozapine-studied research subjects with schizophrenia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sanyal AJ et al. (2025). Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Reply [PMID: 40834312]
Laboratory literature summary: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Neves JS et al. (2024). Semaglutide and Cardiovascular Outcomes [PMID: 38381686]
Laboratory literature summary: Semaglutide and Cardiovascular Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taqueti VR et al. (2024). Semaglutide and Cardiovascular Outcomes [PMID: 38381682]
Laboratory literature summary: Semaglutide and Cardiovascular Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Belkhouribchia J (2024). Semaglutide and Cardiovascular Outcomes [PMID: 38381684]
Laboratory literature summary: Semaglutide and Cardiovascular Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Belalcazar LM et al. (2024). Semaglutide and Cardiovascular Outcomes [PMID: 38381683]
Laboratory literature summary: Semaglutide and Cardiovascular Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Campbell LA et al. (2024). Semaglutide and Cardiovascular Outcomes [PMID: 38381685]
Laboratory literature summary: Semaglutide and Cardiovascular Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alkhatib M et al. (2025). The multifaceted effects of semaglutide: exploring its broad investigational applications [PMID: 40904035]
Laboratory literature summary: The multifaceted effects of semaglutide: exploring its broad investigational applications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Christou GA et al. (2019). Semaglutide as a promising antiobesity drug [PMID: 30768766]
Laboratory literature summary: Semaglutide as a promising antiobesity drug. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Agarwal SM et al. (2024). Semaglutide in Psychiatry-Opportunities and Challenges [PMID: 39167395]
Laboratory literature summary: Semaglutide in Psychiatry-Opportunities and Challenges. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lincoff AM et al. (2024). Semaglutide and Cardiovascular Outcomes. Reply [PMID: 38381687]
Laboratory literature summary: Semaglutide and Cardiovascular Outcomes. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Barbagelata L et al. (2024). Semaglutide and heart failure: Updated meta-analysis [PMID: 38908729]
Laboratory literature summary: Semaglutide and heart failure: Updated meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aronne LJ (2025). Tirzepatide vs. Semaglutide for metabolic research models investigation. Reply [PMID: 41124644]
Laboratory literature summary: Tirzepatide vs. Semaglutide for metabolic research models investigation. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yan H et al. (2024). Cardiometabolic Modulation by Semaglutide Contributes to Cardioprotection in Rats with… [PMID: 39640291]
Laboratory literature summary: Cardiometabolic Modulation by Semaglutide Contributes to Cardioprotection in Rats with Myocardial Infarction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderson SL et al. (2020). Laboratory research record on GLP-1S [PMID: 31952996]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Crunkhorn S (2025). Understanding semaglutide action in the brain [PMID: 40555764]
Laboratory literature summary: Understanding semaglutide action in the brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McGuire DK et al. (2025). Oral Semaglutide and Cardiovascular Outcomes. Reply [PMID: 40802953]
Laboratory literature summary: Oral Semaglutide and Cardiovascular Outcomes. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liava C et al. (2021). Semaglutide for nonalcoholic steatohepatitis: closer to a solution? [PMID: 34430539]
Laboratory literature summary: Semaglutide for nonalcoholic steatohepatitis: closer to a solution?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lum F (2025). Association of Semaglutide and NAION Reviewed [PMID: 40569602]
Laboratory literature summary: Association of Semaglutide and NAION Reviewed. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carbone S et al. (2025). Semaglutide in HFpEF and metabolic research models: Targeting Both for Functional Gains [PMID: 40992091]
Laboratory literature summary: Semaglutide in HFpEF and metabolic research models: Targeting Both for Functional Gains. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abdullayev N et al. (2025). Tirzepatide vs. Semaglutide for metabolic research models investigation [PMID: 41124643]
Laboratory literature summary: Tirzepatide vs. Semaglutide for metabolic research models investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fezza R et al. (2023). Emerging Anesthesia Risks with Semaglutide [PMID: 38025626]
Laboratory literature summary: Emerging Anesthesia Risks with Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lexchin J et al. (2023). Semaglutide: a new drug for the investigation of metabolic research models [PMID: 37879878]
Laboratory literature summary: Semaglutide: a new drug for the investigation of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
The Lancet Regional Health-Europe (2024). Semaglutide and beyond: a turning point in metabolic research models pharmacotherapy [PMID: 38362559]
Laboratory literature summary: Semaglutide and beyond: a turning point in metabolic research models pharmacotherapy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bonnesen K et al. (2025). Laboratory research record on GLP-1S [PMID: 41334697]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Barnett MJL et al. (2025). Semaglutide research protocol and iatrogenic thyrotoxicosis [PMID: 40638337]
Laboratory literature summary: Semaglutide research protocol and iatrogenic thyrotoxicosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ferrara F et al. (2025). Progress and challenges in metabolic research models pharmacotherapy: semaglutide as a… [PMID: 40515833]
Laboratory literature summary: Progress and challenges in metabolic research models pharmacotherapy: semaglutide as a milestone. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kalra S et al. (2022). Oral Semaglutide: exposure design in Special Situations [PMID: 35532859]
Laboratory literature summary: Oral Semaglutide: exposure design in Special Situations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xiao Y et al. (2019). Laboratory research record on GLP-1S [PMID: 31591979]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Puntis JW (2026). Semaglutide for metabolic research models: a pill for every ill? [PMID: 41916684]
Laboratory literature summary: Semaglutide for metabolic research models: a pill for every ill?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kruse T et al. (2024). Redefining peptide therapeutics with semaglutide [PMID: 38321235]
Laboratory literature summary: Redefining peptide therapeutics with semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Basile L et al. (2024). Semaglutide and metabolic research models: beyond the nutritional and lifestyle… [PMID: 39028209]
Laboratory literature summary: Semaglutide and metabolic research models: beyond the nutritional and lifestyle intervention?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Laboratory research record on GLP-1S [PMID: 41060673]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dandona P et al. (2023). Laboratory research record on GLP-1S [PMID: 37672701]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Prodam F (2024). Is semaglutide a target research protocol for acquired hypothalamic metabolic research… [PMID: 39212830]
Laboratory literature summary: Is semaglutide a target research protocol for acquired hypothalamic metabolic research models?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Evola V et al. (2026). Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of… [PMID: 41504939]
Laboratory literature summary: Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anastasiou IA et al. (2025). Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro [PMID: 41012453]
Laboratory literature summary: Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Phillips A et al. (2022). Laboratory research record on GLP-1S [PMID: 34964141]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Latini R et al. (2021). Semaglutide and effective weight control [PMID: 33667415]
Laboratory literature summary: Semaglutide and effective weight control. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
De Luca L et al. (2024). [ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders] [PMID: 39588627]
Laboratory literature summary: [ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Herrington WG et al. (2024). Laboratory research record on GLP-1S [PMID: 38986062]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Tentolouris A et al. (2026). Laboratory research record on GLP-1S [PMID: 41565568]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Tzoulis P et al. (2024). Semaglutide for body-composition research: unanswered questions [PMID: 38904050]
Laboratory literature summary: Semaglutide for body-composition research: unanswered questions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2024). Semaglutide and risk of suicidal ideations [PMID: 38182786]
Laboratory literature summary: Semaglutide and risk of suicidal ideations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Binu AJ et al. (2024). Cardiovascular Implications of Semaglutide in metabolic research models Management:… [PMID: 39006466]
Laboratory literature summary: Cardiovascular Implications of Semaglutide in metabolic research models Management: Redefining Cardiovascular Health Strategies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Smits MM et al. (2021). Corrigendum: laboratory profile of Semaglutide [PMID: 34858353]
Laboratory literature summary: Corrigendum: laboratory profile of Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schattenberg JM et al. (2025). Proteomic signatures reflect effects of semaglutide investigation for MASH [PMID: 40980163]
Laboratory literature summary: Proteomic signatures reflect effects of semaglutide investigation for MASH. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Krammer T et al. (2025). Cardioprotective effects of semaglutide on isolated research subjects ventricular… [PMID: 40107718]
Laboratory literature summary: Cardioprotective effects of semaglutide on isolated research subjects ventricular myocardium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Manjoo P et al. (2023). Oral semaglutide: an OASIS from parenteral-route administration [PMID: 37633662]
Laboratory literature summary: Oral semaglutide: an OASIS from parenteral-route administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
De Luca L et al. (2025). ANMCO statement: semaglutide in the cardio-nephro-metabolic continuum [PMID: 40385470]
Laboratory literature summary: ANMCO statement: semaglutide in the cardio-nephro-metabolic continuum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wharton S et al. (2025). Laboratory research record on GLP-1S [PMID: 41370813]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
O'Leary K (2025). Semaglutide treats MASH liver disease [PMID: 40442483]
Laboratory literature summary: Semaglutide treats MASH liver disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahmed M et al. (2025). First-Line research protocol: Semaglutide Rise [PMID: 41264827]
Laboratory literature summary: First-Line research protocol: Semaglutide Rise. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chi H et al. (2025). Laboratory research record on GLP-1S [PMID: 41259767]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Fornes A et al. (2022). Laboratory research record on GLP-1S [PMID: 35832567]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Malozowski S (2023). Once-Weekly Semaglutide in Adolescents with metabolic research models [PMID: 36947475]
Laboratory literature summary: Once-Weekly Semaglutide in Adolescents with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Snaith JR et al. (2023). Once-Weekly Semaglutide in Adolescents with metabolic research models [PMID: 36947474]
Laboratory literature summary: Once-Weekly Semaglutide in Adolescents with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Blüher M et al. (2021). [metabolic research models investigation with semaglutide] [PMID: 34402956]
Laboratory literature summary: [metabolic research models investigation with semaglutide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grillo R et al. (2025). Semaglutide Awareness in Maxillofacial Surgery [PMID: 41607581]
Laboratory literature summary: Semaglutide Awareness in Maxillofacial Surgery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rivera-Esteban J et al. (2025). Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis [PMID: 40834310]
Laboratory literature summary: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lavender J et al. (2025). Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis [PMID: 40834309]
Laboratory literature summary: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Su CY et al. (2025). Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis [PMID: 40834311]
Laboratory literature summary: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2020). Laboratory research record on GLP-1S [PMID: 32921892]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Talasila S et al. (2025). Semaglutide-induced fixed drug eruption [PMID: 39845462]
Laboratory literature summary: Semaglutide-induced fixed drug eruption. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Katsiki N et al. (2017). Semaglutide, lipid-lowering drugs, and NAFLD [PMID: 28434490]
Laboratory literature summary: Semaglutide, lipid-lowering drugs, and NAFLD. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suresh J et al. (2025). Blinded by the drug? A vigilyze signal linking semaglutide to NAION [PMID: 41026313]
Laboratory literature summary: Blinded by the drug? A vigilyze signal linking semaglutide to NAION. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang X et al. (2025). The observed endpoints of Semaglutide on Hypothalamic metabolic research models Caused… [PMID: 40432243]
Laboratory literature summary: The observed endpoints of Semaglutide on Hypothalamic metabolic research models Caused by Craniopharyngioma Surgery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Seferović PM et al. (2025). New perspectives on semaglutide in cardiovascular disease [PMID: 41206157]
Laboratory literature summary: New perspectives on semaglutide in cardiovascular disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alanazi M et al. (2024). Laboratory research record on GLP-1S [PMID: 39328692]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (2024). Laboratory research record on GLP-1S [PMID: 38691645]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Scheen AJ (2022). Add-on value of tirzepatide versus semaglutide [PMID: 35468323]
Laboratory literature summary: Add-on value of tirzepatide versus semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gnanapragasam H et al. (2020). Laboratory research record on GLP-1S [PMID: 32232400]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Venkatakrishnan AJ et al. (2026). Body-composition research dynamics with tirzepatide versus semaglutide [PMID: 42311474]
Laboratory literature summary: body-composition research dynamics with tirzepatide versus semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Modesto-Lowe V et al. (2026). Semaglutide for Alcohol Use Disorder [PMID: 41499192]
Laboratory literature summary: Semaglutide for Alcohol Use Disorder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pagidipati NJ (2024). Six Substudies From the Semaglutide Trials: Identifying Mechanisms of Benefit and Whom… [PMID: 39218241]
Laboratory literature summary: Six Substudies From the Semaglutide Trials: Identifying Mechanisms of Benefit and Whom to Treat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Podolsky MI et al. (2025). Factors Associated With Semaglutide Initiation Among Adults With metabolic research models [PMID: 39836425]
Laboratory literature summary: Factors Associated With Semaglutide Initiation Among Adults With metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Choy K et al. (2024). Weighing your options-intragastric balloon versus semaglutide [PMID: 39138683]
Laboratory literature summary: Weighing your options-intragastric balloon versus semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jamshed N et al. (2025). Neuropsychiatric observed outcomes in study models of semaglutide in research subjects with dementia [PMID: 40759509]
Laboratory literature summary: Neuropsychiatric observed outcomes in study models of semaglutide in research subjects with dementia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hahn AW et al. (2025). Laboratory research record on GLP-1S [PMID: 40971637]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Peter R et al. (2020). Laboratory research record on GLP-1S [PMID: 32428416]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Zamir D et al. (2025). Laboratory research record on GLP-1S [PMID: 40849680]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Bald E et al. (2023). Laboratory research record on GLP-1S [PMID: 36689981]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Pan X et al. (2025). Semaglutide attenuates lipotoxicity-induced cardiac injury by inhibiting Slc27a2… [PMID: 40456371]
Laboratory literature summary: Semaglutide attenuates lipotoxicity-induced cardiac injury by inhibiting Slc27a2 expression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hughes K et al. (2024). Acute Pancreatitis Likely Due to Semaglutide [PMID: 39308839]
Laboratory literature summary: Acute Pancreatitis Likely Due to Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Misra S (2024). Deciphering the Effects of Semaglutide Across the Glycemic Spectrum [PMID: 38907681]
Laboratory literature summary: Deciphering the Effects of Semaglutide Across the Glycemic Spectrum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hsu AY et al. (2025). NAION risk with semaglutide: what we know so far [PMID: 40335680]
Laboratory literature summary: NAION risk with semaglutide: what we know so far. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu G et al. (2025). Laboratory research record on GLP-1S [PMID: 40966636]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Da BL et al. (2021). Semaglutide or control arm for Nonalcoholic Steatohepatitis [PMID: 34233104]
Laboratory literature summary: Semaglutide or control arm for Nonalcoholic Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Barton Duell P et al. (2025). Oral semaglutide and reduction in major adverse cardiovascular events [PMID: 40250965]
Laboratory literature summary: Oral semaglutide and reduction in major adverse cardiovascular events. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wade FG et al. (2025). Bridging the Gap to Waitlist Activation: Semaglutide's body-composition research… [PMID: 41075262]
Laboratory literature summary: Bridging the Gap to Waitlist Activation: Semaglutide's body-composition research observed endpoints and laboratory profile in research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rijk PC (2024). Laboratory research record on GLP-1S [PMID: 39606869]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Sun M et al. (2026). Interpreting Post-Discontinuation Trajectories After Semaglutide or Tirzepatide [PMID: 41873004]
Laboratory literature summary: Interpreting Post-Discontinuation Trajectories After Semaglutide or Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harris E (2023). Semaglutide Improves Heart Failure and Cardiovascular Disease [PMID: 37672290]
Laboratory literature summary: Semaglutide Improves Heart Failure and Cardiovascular Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jensterle M et al. (2023). Semaglutide in metabolic research models: Unmet Needs in research subjects [PMID: 36609945]
Laboratory literature summary: Semaglutide in metabolic research models: Unmet Needs in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
DeVries JH (2024). Laboratory research record on GLP-1S [PMID: 38231640]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Weinrauch LA et al. (2024). Laboratory research record on GLP-1S [PMID: 38231641]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dagli N et al. (2023). An Update on Semaglutide Research: A Bibliometric Analysis and a Literature Review [PMID: 37808605]
Laboratory literature summary: An Update on Semaglutide Research: A Bibliometric Analysis and a Literature Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kermansaravi M et al. (2025). Laboratory research record on GLP-1S [PMID: 41370811]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Gaglia JL et al. (2024). Laboratory research record on GLP-1S [PMID: 38231642]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Middeldorp ME et al. (2025). Semaglutide After Catheter Ablation: A New Chapter in Atrial Fibrillation Care? [PMID: 41159264]
Laboratory literature summary: Semaglutide After Catheter Ablation: A New Chapter in Atrial Fibrillation Care?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schneider LS (2026). Semaglutide for neurodegeneration research models's disease after evoke and evoke [PMID: 41865757]
Laboratory literature summary: Semaglutide for neurodegeneration research models's disease after evoke and evoke. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aman Y (2025). Semaglutide alleviates knee osteoarthritis pain in persons with metabolic research models [PMID: 39810052]
Laboratory literature summary: Semaglutide alleviates knee osteoarthritis pain in persons with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2019). Laboratory research record on GLP-1S [PMID: 31770356]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Jamialahmadi T et al. (2025). Beyond fat: Does semaglutide affect lean mass? [PMID: 39647240]
Laboratory literature summary: Beyond fat: Does semaglutide affect lean mass?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Castellanos V et al. (2024). Semaglutide-Induced Lupus Erythematosus With Multiorgan Involvement [PMID: 38559525]
Laboratory literature summary: Semaglutide-Induced Lupus Erythematosus With Multiorgan Involvement. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2026). FDA Approves Higher-exposure level parenteral-route administration Semaglutide [PMID: 41931277]
Laboratory literature summary: FDA Approves Higher-exposure level parenteral-route administration Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dayer VW et al. (2025). Comprehensive Access to Semaglutide: laboratory and Economic Implications for Medicare [PMID: 40701338]
Laboratory literature summary: Comprehensive Access to Semaglutide: laboratory and Economic Implications for Medicare. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lake JE et al. (2026). Semaglutide improves markers of cardiovascular risk in people with HIV [PMID: 42084141]
Laboratory literature summary: Semaglutide improves markers of cardiovascular risk in people with HIV. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hennessy S et al. (2026). Structural Assumptions in Semaglutide Cost-Effectiveness-Reply [PMID: 42160096]
Laboratory literature summary: Structural Assumptions in Semaglutide Cost-Effectiveness-Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zavaleta-Monestel E et al. (2026). Structural Assumptions in Semaglutide Cost-Effectiveness [PMID: 42160088]
Laboratory literature summary: Structural Assumptions in Semaglutide Cost-Effectiveness. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abouelmagd AA et al. (2025). Semaglutide and MASH resolution: A pooled analysis of recent trials [PMID: 40726455]
Laboratory literature summary: Semaglutide and MASH resolution: A pooled analysis of recent trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Natale F et al. (2024). Semaglutide in Cardiometabolic Diseases: SELECTing the Target Population [PMID: 38786967]
Laboratory literature summary: Semaglutide in Cardiometabolic Diseases: SELECTing the Target Population. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Obando Pacheco J et al. (2026). Secondary alopecia due to semaglutide [PMID: 42364353]
Laboratory literature summary: Secondary alopecia due to semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Neumann J et al. (2024). Contractile Effects of Semaglutide in the research subjects Atrium [PMID: 39339176]
Laboratory literature summary: Contractile Effects of Semaglutide in the research subjects Atrium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gupta S et al. (2026). Semaglutide Hype or Hope: Evidence-based Review in Diabesity [PMID: 41818107]
Laboratory literature summary: Semaglutide Hype or Hope: Evidence-based Review in Diabesity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Basdas R et al. (2025). Semaglutide Modulates Proinflammatory Epicardial Adipogenesis With Paracrine Effects… [PMID: 40471762]
Laboratory literature summary: Semaglutide Modulates Proinflammatory Epicardial Adipogenesis With Paracrine Effects on hiPSC-Atrial Cardiomyocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cesaro A et al. (2026). Tirzepatide and semaglutide: different twins? [PMID: 42099488]
Laboratory literature summary: Tirzepatide and semaglutide: different twins?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mollan SP (2024). Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy [PMID: 38958953]
Laboratory literature summary: Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Amaro A et al. (2022). Cardiometabolic risk factors observed endpoints of semaglutide in the STEP program [PMID: 36691308]
Laboratory literature summary: Cardiometabolic risk factors observed endpoints of semaglutide in the STEP program. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Becerril S et al. (2021). Cagrilintide plus semaglutide for metabolic research models management [PMID: 33894837]
Laboratory literature summary: Cagrilintide plus semaglutide for metabolic research models management. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhou L et al. (2024). Laboratory research record on GLP-1S [PMID: 38678781]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Piątkowska-Chmiel I et al. (2025). Laboratory research record on GLP-1S [PMID: 40059125]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Gasoyan H et al. (2026). Coverage is the Key to Realizing the Promise of Semaglutide [PMID: 41559293]
Laboratory literature summary: Coverage is the Key to Realizing the Promise of Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lim GB (2016). Laboratory research record on GLP-1S [PMID: 27708277]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Ojeniran M et al. (2021). Semaglutide for body-composition research [PMID: 34772713]
Laboratory literature summary: Semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schweitzer K (2026). What to Know About the New Semaglutide Pill for metabolic research models [PMID: 41543841]
Laboratory literature summary: What to Know About the New Semaglutide Pill for metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Giugliano D et al. (2025). Semaglutide cuts kidney risk in metabolic research models [PMID: 39495477]
Laboratory literature summary: Semaglutide cuts kidney risk in metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rizzo JF 3rd et al. (2025). Semaglutide and Risk of NAION-Additional Insights [PMID: 39976950]
Laboratory literature summary: Semaglutide and Risk of NAION-Additional Insights. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rosen CJ (2025). Laboratory research record on GLP-1S [PMID: 40550008]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Sheth K et al. (2024). Wernicke Encephalopathy Associated With Semaglutide Use [PMID: 38975533]
Laboratory literature summary: Wernicke Encephalopathy Associated With Semaglutide Use. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Weghuber D et al. (2023). Once-Weekly Semaglutide in Adolescents with metabolic research models. Reply [PMID: 36947476]
Laboratory literature summary: Once-Weekly Semaglutide in Adolescents with metabolic research models. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lam SHM et al. (2025). In HFpEF, semaglutide reduced a composite of worsening HF or CV death [PMID: 39761583]
Laboratory literature summary: In HFpEF, semaglutide reduced a composite of worsening HF or CV death. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nguyen T et al. (2023). Evaluating the observed endpoints and Pharmacoeconomics of Semaglutide and Tirzepatide… [PMID: 37449929]
Laboratory literature summary: Evaluating the observed endpoints and Pharmacoeconomics of Semaglutide and Tirzepatide in the Setting of metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nolan T (2025). Low exposure level oral semaglutide for metabolic research models… and other research [PMID: 41067754]
Laboratory literature summary: Low exposure level oral semaglutide for metabolic research models… and other research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jones T et al. (2025). Granuloma annulare after starting semaglutide [PMID: 40642503]
Laboratory literature summary: Granuloma annulare after starting semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
O'Leary K (2023). Semaglutide offers new route to cardiovascular risk reduction [PMID: 38036698]
Laboratory literature summary: Semaglutide offers new route to cardiovascular risk reduction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McCartney M (2023). Semaglutide: should the media slim down its enthusiasm? [PMID: 36931642]
Laboratory literature summary: Semaglutide: should the media slim down its enthusiasm?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ravindhran B et al. (2026). The STRIDE Trial and Semaglutide: Implications for laboratory Vascular Practice [PMID: 42462869]
Laboratory literature summary: The STRIDE Trial and Semaglutide: Implications for laboratory Vascular Practice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Weiskirchen R et al. (2025). How 'miracle' body-composition research semaglutide promises to change medicine but… [PMID: 39947645]
Laboratory literature summary: How 'miracle' body-composition research semaglutide promises to change medicine but can we afford the expense?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fallows E et al. (2023). Semaglutide and the future of metabolic research models care in the UK [PMID: 37290459]
Laboratory literature summary: Semaglutide and the future of metabolic research models care in the UK. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harris E (2023). Laboratory research record on GLP-1S [PMID: 38019508]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Nicolau J et al. (2026). Semaglutide in research subjects with hidradenitis suppurativa and metabolic research… [PMID: 41832804]
Laboratory literature summary: Semaglutide in research subjects with hidradenitis suppurativa and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Essilfie-Quaye K et al. (2025). Semaglutide-Induced Silent Aspiration: An Unrecognised Cause of Organising Pneumonia [PMID: 40625884]
Laboratory literature summary: Semaglutide-Induced Silent Aspiration: An Unrecognised Cause of Organising Pneumonia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2024). Effect of semaglutide on major cardiovascular events [PMID: 38237952]
Laboratory literature summary: Effect of semaglutide on major cardiovascular events. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schmidt MA et al. (2026). Ketone research protocol prevents semaglutide-induced loss of cardiac mass [PMID: 41026893]
Laboratory literature summary: Ketone research protocol prevents semaglutide-induced loss of cardiac mass. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Suki M et al. (2025). Semaglutide in MASLD research subjects: Improved Survival and Liver Outcomes [PMID: 40732362]
Laboratory literature summary: Semaglutide in MASLD research subjects: Improved Survival and Liver Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Daly T et al. (2025). Targeting dementia prevention with semaglutide: The case for APOE4 homozygotes [PMID: 40572012]
Laboratory literature summary: Targeting dementia prevention with semaglutide: The case for APOE4 homozygotes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sumithran P et al. (2025). Growing evidence for semaglutide observed endpoints in Asian adults with metabolic… [PMID: 40825341]
Laboratory literature summary: Growing evidence for semaglutide observed endpoints in Asian adults with metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Klein KR et al. (2026). Laboratory profile of Semaglutide After Dialysis Initiation: An Individual-Level… [PMID: 41893299]
Laboratory literature summary: laboratory profile of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lens S (2026). Semaglutide in MASH: A Promising Step Forward With Room for Improvement [PMID: 40712938]
Laboratory literature summary: Semaglutide in MASH: A Promising Step Forward With Room for Improvement. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Koureta E et al. (2024). Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration [PMID: 38464718]
Laboratory literature summary: Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang L et al. (2024). Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2 [PMID: 39634723]
Laboratory literature summary: Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Novograd J et al. (2022). Semaglutide for body-composition research: Was It Worth the Weight? [PMID: 36201244]
Laboratory literature summary: Semaglutide for body-composition research: Was It Worth the Weight?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Belcourt J et al. (2026). Laboratory research record on GLP-1S [PMID: 41689811]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Yaribeygi H et al. (2024). Exploring the antioxidant properties of semaglutide: A comprehensive review [PMID: 39549371]
Laboratory literature summary: Exploring the antioxidant properties of semaglutide: A comprehensive review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Byun S et al. (2025). Advantage of Semaglutide: Comprehensive Analysis of Metabolic Impact of… [PMID: 41405347]
Laboratory literature summary: Advantage of Semaglutide: Comprehensive Analysis of Metabolic Impact of Semaglutide-studied and Pair-Fed Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kyrillos JV et al. (2022). Integrating semaglutide into metabolic research models management – a primary care… [PMID: 36691306]
Laboratory literature summary: Integrating semaglutide into metabolic research models management – a primary care perspective. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ryan DH (2021). Semaglutide for metabolic research models: four STEPs forward, but more to come [PMID: 33864806]
Laboratory literature summary: Semaglutide for metabolic research models: four STEPs forward, but more to come. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Korda M (2024). Semaglutide may reduce cardiovascular disease and heart failure [PMID: 39367214]
Laboratory literature summary: Semaglutide may reduce cardiovascular disease and heart failure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Korda M (2024). Semaglutide improves cardiovascular health independently of body-composition research [PMID: 39196231]
Laboratory literature summary: Semaglutide improves cardiovascular health independently of body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harris E (2024). Semaglutide Linked With Lower Risk of Suicidal Thoughts [PMID: 38265825]
Laboratory literature summary: Semaglutide Linked With Lower Risk of Suicidal Thoughts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Casazza JA et al. (2024). Semaglutide in research subjects Undergoing Anesthesia for Otolaryngologic Procedures [PMID: 38038217]
Laboratory literature summary: Semaglutide in research subjects Undergoing Anesthesia for Otolaryngologic Procedures. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xu Y et al. (2025). Laboratory research record on GLP-1S [PMID: 40464214]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hussar DA et al. (2018). Semaglutide, Ertugliflozin, and Deflazacort [PMID: 29739505]
Laboratory literature summary: Semaglutide, Ertugliflozin, and Deflazacort. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cai CX et al. (2025). Association of Semaglutide and NAION Reviewed-Reply [PMID: 40569577]
Laboratory literature summary: Association of Semaglutide and NAION Reviewed-Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Klonoff DC et al. (2025). Association of Semaglutide and NAION Reviewed [PMID: 40569601]
Laboratory literature summary: Association of Semaglutide and NAION Reviewed. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ahern S (2025). Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide [PMID: 41210042]
Laboratory literature summary: Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Öngür D (2026). Semaglutide in Schizophrenia-A Top laboratory Trial [PMID: 42384388]
Laboratory literature summary: Semaglutide in Schizophrenia-A Top laboratory Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Laboratory research record on GLP-1S [PMID: 40009989]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Yan M et al. (2024). Laboratory research record on GLP-1S [PMID: 38647981]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Belcourt J et al. (2025). Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and… [PMID: 39285774]
Laboratory literature summary: Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and Tirzepatide "For Research Purposes". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Newsome PN et al. (2021). Semaglutide or control arm for Nonalcoholic Steatohepatitis. Reply [PMID: 34233105]
Laboratory literature summary: Semaglutide or control arm for Nonalcoholic Steatohepatitis. Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wadden TA et al. (2025). Mental Health Factors in Semaglutide Discontinuation-Reply [PMID: 40094647]
Laboratory literature summary: Mental Health Factors in Semaglutide Discontinuation-Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Endo M et al. (2025). Mental Health Factors in Semaglutide Discontinuation [PMID: 40094686]
Laboratory literature summary: Mental Health Factors in Semaglutide Discontinuation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang Z et al. (2024). The laboratory profile of semaglutide in research subjects with depression and… [PMID: 39497569]
Laboratory literature summary: The laboratory profile of semaglutide in research subjects with depression and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Acosta AA et al. (2026). Chronic semaglutide alters ingestive behavior without impairing taste function in mice [PMID: 42364710]
Laboratory literature summary: Chronic semaglutide alters ingestive behavior without impairing taste function in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shahmohamadi E et al. (2025). Weight for Rhythm: Is the Evidence for AF Risk with Semaglutide Still Premature? [PMID: 40638784]
Laboratory literature summary: Weight for Rhythm: Is the Evidence for AF Risk with Semaglutide Still Premature?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Borkum M et al. (2022). Semaglutide-Associated Acute Interstitial Nephritis: A Case Report [PMID: 36471818]
Laboratory literature summary: Semaglutide-Associated Acute Interstitial Nephritis: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lavie CJ et al. (2023). Editorial commentary: body-composition research for cardiovascular disease prevention… [PMID: 34999021]
Laboratory literature summary: Editorial commentary: body-composition research for cardiovascular disease prevention – is semaglutide the answer?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Agarwal R (2025). Laboratory research record on GLP-1S [PMID: 41115233]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Wilding JPH (2019). Laboratory research record on GLP-1S [PMID: 31591978]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Chamberlin S et al. (2019). Laboratory research record on GLP-1S [PMID: 31305048]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Fernández-Ruiz I (2023). Semaglutide is beneficial in research subjects with HFpEF and metabolic research models [PMID: 37709935]
Laboratory literature summary: Semaglutide is beneficial in research subjects with HFpEF and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bril F (2023). Semaglutide in NASH-related cirrhosis: too late to the party? [PMID: 36934739]
Laboratory literature summary: Semaglutide in NASH-related cirrhosis: too late to the party?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jung HN et al. (2022). The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against metabolic research… [PMID: 35314521]
Laboratory literature summary: The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against metabolic research models: STEP or SURPASS?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Patel F et al. (2023). Acute Pancreatitis in a research subjects Taking Semaglutide [PMID: 37731423]
Laboratory literature summary: Acute Pancreatitis in a research subjects Taking Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ghosh A et al. (2025). From abdominal adiposity to liver fibrosis: Expanding promise of semaglutide for Asian… [PMID: 41071271]
Laboratory literature summary: From abdominal adiposity to liver fibrosis: Expanding promise of semaglutide for Asian Indians. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Memon A et al. (2023). Semaglutide: new dawn for diabetics [PMID: 36932797]
Laboratory literature summary: Semaglutide: new dawn for diabetics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ouellette S et al. (2023). Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports [PMID: 37026881]
Laboratory literature summary: Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fagiola M (2025). Semaglutide and GLP-1 Agonists: Forensic and Medicolegal Implications [PMID: 40261091]
Laboratory literature summary: Semaglutide and GLP-1 Agonists: Forensic and Medicolegal Implications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gatto L et al. (2025). From the SELECT study to SOUL: different administration methods of semaglutide but… [PMID: 40248301]
Laboratory literature summary: From the SELECT study to SOUL: different administration methods of semaglutide but same observed endpoints?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Leehey DJ et al. (2021). Acute Kidney Injury Associated With Semaglutide [PMID: 33851124]
Laboratory literature summary: Acute Kidney Injury Associated With Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Scannell C et al. (2024). Laboratory research record on GLP-1S [PMID: 39093590]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Arvanitakis M (2024). No More Needles: Oral Semaglutide for body-composition research [PMID: 38253185]
Laboratory literature summary: No More Needles: Oral Semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2026). Laboratory research record on GLP-1S [PMID: 41575765]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Rong X et al. (2025). Microglial activation and hypothalamic structural plasticity in HFD metabolic research… [PMID: 39724960]
Laboratory literature summary: Microglial activation and hypothalamic structural plasticity in HFD metabolic research models: insights from semaglutide and minocycline. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Langeskov EK et al. (2022). Population pharmacokinetic of paracetamol and atorvastatin with co-administration of… [PMID: 35799471]
Laboratory literature summary: Population pharmacokinetic of paracetamol and atorvastatin with co-administration of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iorio F et al. (2024). [Semaglutide in Chronic Kidney Disease: Great Enthusiasm. But How Does It Work?] [PMID: 38943325]
Laboratory literature summary: [Semaglutide in Chronic Kidney Disease: Great Enthusiasm. But How Does It Work?]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bin Dayel FF (2025). Laboratory research record on GLP-1S [PMID: 41302309]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Bager MD et al. (2026). Hormonal Contraception and Initiation of Semaglutide research protocol [PMID: 42485041]
Laboratory literature summary: Hormonal Contraception and Initiation of Semaglutide research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grant JE et al. (2026). Response of Gambling Disorder to Semaglutide [PMID: 41410610]
Laboratory literature summary: Response of Gambling Disorder to Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2023). Semaglutide for body-composition research: Was It Worth the Weight?: Erratum [PMID: 36469361]
Laboratory literature summary: Semaglutide for body-composition research: Was It Worth the Weight?: Erratum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kluger AY et al. (2018). Semaglutide and GLP-1 analogues as body-composition research agents [PMID: 30122306]
Laboratory literature summary: Semaglutide and GLP-1 analogues as body-composition research agents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brown A et al. (2026). Real-World Effectiveness of Semaglutide and Tirzepatide Compared With Bariatric Surgery [PMID: 42345739]
Laboratory literature summary: Real-World Effectiveness of Semaglutide and Tirzepatide Compared With Bariatric Surgery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Riccio E et al. (2025). Laboratory research record on GLP-1S [PMID: 40338621]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Rodriguez PJ et al. (2025). Semaglutide vs Tirzepatide Dosages for body-composition research-Reply [PMID: 39585685]
Laboratory literature summary: Semaglutide vs Tirzepatide Dosages for body-composition research-Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Levy ME et al. (2025). Semaglutide vs Tirzepatide Dosages for body-composition research [PMID: 39585682]
Laboratory literature summary: Semaglutide vs Tirzepatide Dosages for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2025). Semaglutide Shows Promise in Reducing Alcohol Cravings [PMID: 40085100]
Laboratory literature summary: Semaglutide Shows Promise in Reducing Alcohol Cravings. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Semaglutide and nonarteritic anterior ischaemic optic neuropathy [PMID: 39870391]
Laboratory literature summary: Semaglutide and nonarteritic anterior ischaemic optic neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dickson I (2021). Semaglutide is laboratory profile and efficacious for NASH resolution [PMID: 33257834]
Laboratory literature summary: Semaglutide is laboratory profile and efficacious for NASH resolution. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ashinze P et al. (2024). Semaglutide in the spotlight: weighing benefits against rising concerns [PMID: 38188532]
Laboratory literature summary: Semaglutide in the spotlight: weighing benefits against rising concerns. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mahase E (2024). Semaglutide: FDA publishes warning amid reports of research subjects overdosing [PMID: 39079728]
Laboratory literature summary: Semaglutide: FDA publishes warning amid reports of research subjects overdosing. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aschenbrenner DS (2023). Laboratory research record on GLP-1S [PMID: 37233137]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Billings SA et al. (2023). Rhabdomyolysis Associated With Semaglutide research protocol: A Case Report [PMID: 38192938]
Laboratory literature summary: Rhabdomyolysis Associated With Semaglutide research protocol: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Meca AD et al. (2024). Unlocking the Potential: Semaglutide's Impact on neurodegeneration research models's… [PMID: 38921025]
Laboratory literature summary: Unlocking the Potential: Semaglutide's Impact on neurodegeneration research models's and neurodegeneration research models's Disease in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huang X (2025). "Why you should (not) use semaglutide?": A critical discourse analysis on health… [PMID: 40582256]
Laboratory literature summary: "Why you should (not) use semaglutide?": A critical discourse analysis on health professionals' videos of semaglutide for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gupta N et al. (2024). Semaglutide in Heart Failure: A Systematic Review of Outcomes of Semaglutide in Heart… [PMID: 39149678]
Laboratory literature summary: Semaglutide in Heart Failure: A Systematic Review of Outcomes of Semaglutide in Heart Failure research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alqinai B et al. (2026). Semaglutide-Induced Symptomatic Remission in Ulcerative Colitis [PMID: 41959596]
Laboratory literature summary: Semaglutide-Induced Symptomatic Remission in Ulcerative Colitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jensen L et al. (2018). Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment [PMID: 29205786]
Laboratory literature summary: Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Krakauer JC et al. (2025). Laboratory research record on GLP-1S [PMID: 41259765]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lnu V et al. (2025). Laboratory research record on GLP-1S [PMID: 41259766]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Fogacci F et al. (2025). Laboratory research record on GLP-1S [PMID: 41259764]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Tipa RO et al. (2024). A Systematic Review of Semaglutide's Influence on Cognitive Function in Preclinical… [PMID: 38732190]
Laboratory literature summary: A Systematic Review of Semaglutide's Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jia Q et al. (2026). Advances in proteomics research related to semaglutide: evidence from research… [PMID: 42489869]
Laboratory literature summary: Advances in proteomics research related to semaglutide: evidence from research subjects and animals. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wise J (2023). Semaglutide reduces risk of major cardiovascular events by 20%, finds study [PMID: 37957004]
Laboratory literature summary: Semaglutide reduces risk of major cardiovascular events by 20%, finds study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li Q et al. (2024). Surface-mediated spontaneous emulsification of the acylated peptide, semaglutide [PMID: 38227645]
Laboratory literature summary: Surface-mediated spontaneous emulsification of the acylated peptide, semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2023). Laboratory research record on GLP-1S [PMID: 36757837]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Iacobucci G (2024). Semaglutide: UK regulator approves drug for prevention of cardiovascular events [PMID: 39053933]
Laboratory literature summary: Semaglutide: UK regulator approves drug for prevention of cardiovascular events. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dandona P et al. (2024). Laboratory research record on GLP-1S [PMID: 38231643]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Sattar N et al. (2024). What the SELECT trial of semaglutide means for clinicians [PMID: 38796654]
Laboratory literature summary: What the SELECT trial of semaglutide means for clinicians. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alamgir M et al. (2026). The ESSENCE of hope: what semaglutide's Food and Drug Administration approval means… [PMID: 41983226]
Laboratory literature summary: The ESSENCE of hope: what semaglutide's Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Guerdjikova AI et al. (2024). Semaglutide Misuse in Atypical Anorexia Nervosa-A Case Report [PMID: 38329147]
Laboratory literature summary: Semaglutide Misuse in Atypical Anorexia Nervosa-A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
George M et al. (2023). Fathoming the Role of Semaglutide in metabolic research models Therapeutics [PMID: 37442659]
Laboratory literature summary: Fathoming the Role of Semaglutide in metabolic research models Therapeutics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maher CB et al. (2025). Inflammatory optic neuritis and scleritis following commencement of semaglutide: a… [PMID: 41306396]
Laboratory literature summary: Inflammatory optic neuritis and scleritis following commencement of semaglutide: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Plotkin M et al. (2026). Semaglutide 25 mg Oral Versus Semaglutide 2.4 mg parenteral-route administration: An… [PMID: 42225300]
Laboratory literature summary: Semaglutide 25 mg Oral Versus Semaglutide 2.4 mg parenteral-route administration: An Indirect investigation Comparison of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chopra HK et al. (2026). National Consensus on Semaglutide in Cardiology: From laboratory Evidence to… [PMID: 41818087]
Laboratory literature summary: National Consensus on Semaglutide in Cardiology: From laboratory Evidence to laboratory Translation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Farooqi MF et al. (2024). Portal vein thrombosis in a research subjects on semaglutide [PMID: 39925824]
Laboratory literature summary: Portal vein thrombosis in a research subjects on semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ryan N et al. (2026). Ethical considerations for semaglutide use in children [PMID: 41494820]
Laboratory literature summary: Ethical considerations for semaglutide use in children. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sobieraj J et al. (2024). Exposure level-dependent erythema nodosum after initiation of semaglutide [PMID: 38689866]
Laboratory literature summary: exposure level-dependent erythema nodosum after initiation of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hawkes N (2017). Sixty seconds on… semaglutide [PMID: 29092887]
Laboratory literature summary: Sixty seconds on… semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Han J et al. (2025). Effects of semaglutide on heart failure outcomes [PMID: 39955113]
Laboratory literature summary: Effects of semaglutide on heart failure outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Neves JS et al. (2025). Effects of semaglutide on heart failure outcomes [PMID: 39955112]
Laboratory literature summary: Effects of semaglutide on heart failure outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mahase E (2024). Laboratory research record on GLP-1S [PMID: 39197936]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Baekdal TA et al. (2021). Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A… [PMID: 33750044]
Laboratory literature summary: Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A Pharmacoscintigraphic Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Santulli G (2022). Laboratory research record on GLP-1S [PMID: 35172066]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Kalluru PKR et al. (2026). Semaglutide-induced transient intestinal ischemia: A case report [PMID: 41467632]
Laboratory literature summary: Semaglutide-induced transient intestinal ischemia: A case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Laboratory research record on GLP-1S [PMID: 41575833]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lexchin JR et al. (2025). Weight normativity in action: Semaglutide and metabolic research models [PMID: 39965963]
Laboratory literature summary: Weight normativity in action: Semaglutide and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mahase E (2022). Laboratory research record on GLP-1S [PMID: 35135753]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Chen X et al. (2022). Laboratory research record on GLP-1S [PMID: 36388084]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Goncalves E et al. (2020). Observed endpoints of semaglutide versus liraglutide in laboratory practice [PMID: 31606525]
Laboratory literature summary: observed endpoints of semaglutide versus liraglutide in laboratory practice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sorli C (2017). Semaglutide, lipid-lowering drugs, and NAFLD – Author's reply [PMID: 28434491]
Laboratory literature summary: Semaglutide, lipid-lowering drugs, and NAFLD – Author's reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2025). Tirzepatide Outperforms Semaglutide in Head-to-Head metabolic research models Trial [PMID: 40478570]
Laboratory literature summary: Tirzepatide Outperforms Semaglutide in Head-to-Head metabolic research models Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Carlsson Petri KC et al. (2018). Laboratory research record on GLP-1S [PMID: 29907893]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Jadvani R et al. (2025). From body-composition research to muscle loss: rhabdomyolysis linked to semaglutide [PMID: 41383908]
Laboratory literature summary: From body-composition research to muscle loss: rhabdomyolysis linked to semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Patoulias D et al. (2022). Laboratory research record on GLP-1S [PMID: 35172065]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Boytchev H (2023). Lax oversight of semaglutide advertising could harm research subjects, warn critics [PMID: 38164641]
Laboratory literature summary: Lax oversight of semaglutide advertising could harm research subjects, warn critics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cabral Lopes A et al. (2023). Gastrointestinal disorders potentially associated with Semaglutide: an analysis from… [PMID: 36695099]
Laboratory literature summary: Gastrointestinal disorders potentially associated with Semaglutide: an analysis from the Eudravigilance Database. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Moyad MA (2023). Embracing the Pros and Cons of the New body-composition research Medications… [PMID: 37659049]
Laboratory literature summary: Embracing the Pros and Cons of the New body-composition research Medications (Semaglutide, Tirzepatide, Etc.). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Armanious AJ et al. (2026). Laboratory research record on GLP-1S [PMID: 41512288]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Centor RM et al. (2026). Web Exclusive. Annals On Call – Dulaglutide, Semaglutide, and Tirzepatide: How Do… [PMID: 41554140]
Laboratory literature summary: Web Exclusive. Annals On Call – Dulaglutide, Semaglutide, and Tirzepatide: How Do Gastrointestinal Adverse Effects Compare?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abbasi J (2024). Semaglutide Updates, Hypertension Triple Pills, and More-Heart Health Highlights From… [PMID: 39365594]
Laboratory literature summary: Semaglutide Updates, Hypertension Triple Pills, and More-Heart Health Highlights From ESC Congress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ruder K (2023). As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging [PMID: 37966850]
Laboratory literature summary: As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shaikh AK (2025). Investigational Misconceptions and Weight Outcomes With Semaglutide [PMID: 41140721]
Laboratory literature summary: investigational Misconceptions and Weight Outcomes With Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang J et al. (2026). Insights into semaglutide cardiovascular research: Mechanisms, trials, and frontiers [PMID: 42070764]
Laboratory literature summary: Insights into semaglutide cardiovascular research: Mechanisms, trials, and frontiers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rana KB et al. (2023). Comparison of the Effectiveness of Liraglutide vs Semaglutide in a Veteran Population [PMID: 35414304]
Laboratory literature summary: Comparison of the Effectiveness of Liraglutide vs Semaglutide in a Veteran Population. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harris E (2023). Oral Semaglutide Led to Similar body-composition research as parenteral-route… [PMID: 37256645]
Laboratory literature summary: Oral Semaglutide Led to Similar body-composition research as parenteral-route administration, Company Says. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu Y et al. (2026). Single-exposure level pharmacokinetics of sublingual semaglutide in rats [PMID: 41386332]
Laboratory literature summary: Single-exposure level pharmacokinetics of sublingual semaglutide in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iacobucci G (2023). feeding-behavior endpoints suppressant semaglutide is to be made available to treat metabolic research… [PMID: 36889753]
Laboratory literature summary: feeding-behavior endpoints suppressant semaglutide is to be made available to treat metabolic research models in England. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Grennan KN et al. (2025). Hypokalemia Requiring Hospitalization After Taking Semaglutide parenteral-route… [PMID: 40772190]
Laboratory literature summary: Hypokalemia Requiring Hospitalization After Taking Semaglutide parenteral-route administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chen X et al. (2023). Laboratory research record on GLP-1S [PMID: 37007007]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Sherrill CH et al. (2023). Laboratory research record on GLP-1S [PMID: 37385277]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Rušić D et al. (2025). Semaglutide in the Real World: Attitudes of the Population [PMID: 40981248]
Laboratory literature summary: Semaglutide in the Real World: Attitudes of the Population. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yevusiak T et al. (2026). Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy… [PMID: 42507673]
Laboratory literature summary: Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kumar A et al. (2023). Semaglutide in NASH-related Compensated Cirrhosis: Is There a Silver Lining? [PMID: 37975043]
Laboratory literature summary: Semaglutide in NASH-related Compensated Cirrhosis: Is There a Silver Lining?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Basolo A et al. (2024). Laboratory research record on GLP-1S [PMID: 38157134]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Branch MR et al. (2024). Laboratory Manifestations of Semaglutide Overdose: A Case Study [PMID: 39655973]
Laboratory literature summary: laboratory Manifestations of Semaglutide Overdose: A Case Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tian J et al. (2025). Is Bariatric Surgery at Risk Due to Semaglutide? [PMID: 41568129]
Laboratory literature summary: Is Bariatric Surgery at Risk Due to Semaglutide?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang Y et al. (2024). Laboratory research record on GLP-1S [PMID: 38496002]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
La Vignera S et al. (2026). Unconventional Applications of Semaglutide and Tirzepatide: From Oncology to research… [PMID: 42512116]
Laboratory literature summary: Unconventional Applications of Semaglutide and Tirzepatide: From Oncology to research subjects Reproduction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Slomski A (2021). Semaglutide's body-composition research Benefits Were Sustained in a 2-Year Study [PMID: 34962530]
Laboratory literature summary: Semaglutide's body-composition research Benefits Were Sustained in a 2-Year Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ryan DH (2021). Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and… [PMID: 34518444]
Laboratory literature summary: Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for laboratory Practice?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Powell J et al. (2024). Laboratory research record on GLP-1S [PMID: 38310052]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hean AC et al. (2024). Unremitting Nausea Due to Lurasidone After Semaglutide Initiation [PMID: 39208529]
Laboratory literature summary: Unremitting Nausea Due to Lurasidone After Semaglutide Initiation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sood N et al. (2024). Laboratory research record on GLP-1S [PMID: 39221223]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Jordan V (2025). What effect does semaglutide have on those living with metabolic research models? [PMID: 41346202]
Laboratory literature summary: What effect does semaglutide have on those living with metabolic research models?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stammers J et al. (2026). [Insulin intoxications caused by falsified semaglutide] [PMID: 42390457]
Laboratory literature summary: [Insulin intoxications caused by falsified semaglutide]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gouveri E et al. (2024). Potential New investigational Implications of Semaglutide: New Colours of the Rainbow? [PMID: 37950798]
Laboratory literature summary: Potential New investigational Implications of Semaglutide: New Colours of the Rainbow?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huang YN et al. (2026). Laboratory research record on GLP-1S [PMID: 42373755]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Nayak S et al. (2026). Current trends in semaglutide research protocol and strategies to improve its… [PMID: 42288971]
Laboratory literature summary: Current trends in semaglutide research protocol and strategies to improve its bioavailability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Singh J et al. (2025). Oral semaglutide and cardiovascular outcomes: The overlooked variables [PMID: 40789549]
Laboratory literature summary: Oral semaglutide and cardiovascular outcomes: The overlooked variables. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ruder K (2024). At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide [PMID: 38055301]
Laboratory literature summary: At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Garvey WT et al. (2025). Laboratory research record on GLP-1S [PMID: 41259768]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Davies MJ et al. (2025). Laboratory research record on GLP-1S [PMID: 41259769]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Abbasi J (2023). Highlights From AHA 2023-New Risk Calculator, Semaglutide and CVD, and More [PMID: 37991804]
Laboratory literature summary: Highlights From AHA 2023-New Risk Calculator, Semaglutide and CVD, and More. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Temporelli PL et al. (2025). [Oral semaglutide: why we can no longer do without it?] [PMID: 40292501]
Laboratory literature summary: [Oral semaglutide: why we can no longer do without it?]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ferguson J et al. (2025). Effectiveness of Adjuvant Semaglutide Following Bariatric Metabolic Surgery [PMID: 39982604]
Laboratory literature summary: Effectiveness of Adjuvant Semaglutide Following Bariatric Metabolic Surgery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Humphrey CD et al. (2023). Laboratory research record on GLP-1S [PMID: 38604246]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hsu CK et al. (2025). Analysis of semaglutide's effect on neurodegeneration research models's disease risk [PMID: 39737725]
Laboratory literature summary: Analysis of semaglutide's effect on neurodegeneration research models's disease risk. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ceravolo R et al. (2026). Semaglutide for the Silent Phenotype: A Translational Signal in metabolic research… [PMID: 42342009]
Laboratory literature summary: Semaglutide for the Silent Phenotype: A Translational Signal in metabolic research models-Driven HFpEF. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Qi Y et al. (2026). Semaglutide and improved spinal fusion outcomes: a correspondence [PMID: 40990673]
Laboratory literature summary: Semaglutide and improved spinal fusion outcomes: a correspondence. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hamdar H (2025). The neuroprotective promise of semaglutide for neurodegeneration research models's disease [PMID: 41377300]
Laboratory literature summary: The neuroprotective promise of semaglutide for neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Noor N et al. (2025). Exploring the impact of semaglutide on renal function [PMID: 39312018]
Laboratory literature summary: Exploring the impact of semaglutide on renal function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shi I et al. (2025). Semaglutide Eligibility Across All Current Indications for US Adults [PMID: 39556764]
Laboratory literature summary: Semaglutide Eligibility Across All Current Indications for US Adults. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aranäs C et al. (2023). Antismoking agents do not contribute synergistically to semaglutide's ability to… [PMID: 37719854]
Laboratory literature summary: Antismoking agents do not contribute synergistically to semaglutide's ability to reduce alcohol intake in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Doggrell SA (2020). Laboratory research record on GLP-1S [PMID: 32005073]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Abbasi J (2021). Semaglutide's Success Could Usher in a "New Dawn" for metabolic research models… [PMID: 34160581]
Laboratory literature summary: Semaglutide's Success Could Usher in a "New Dawn" for metabolic research models investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rahman V (2025). The Limitations and Risks Associated With Semaglutide investigation [PMID: 40366642]
Laboratory literature summary: The Limitations and Risks Associated With Semaglutide investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Demmel V et al. (2018). No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects [PMID: 29799100]
Laboratory literature summary: No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shi I et al. (2025). The Limitations and Risks Associated With Semaglutide investigation-Reply [PMID: 40366706]
Laboratory literature summary: The Limitations and Risks Associated With Semaglutide investigation-Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2022). Laboratory research record on GLP-1S [PMID: 35536124]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Admani B et al. (2024). Semaglutide and body-composition research – A concern for diabetics and pharmaceuticals [PMID: 38949006]
Laboratory literature summary: Semaglutide and body-composition research – A concern for diabetics and pharmaceuticals. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Giugliano D et al. (2024). Laboratory research record on GLP-1S [PMID: 39219442]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dong T et al. (2024). Pulmonary aspiration during upper endoscopy in a research subjects prescribed semaglutide [PMID: 39421913]
Laboratory literature summary: Pulmonary aspiration during upper endoscopy in a research subjects prescribed semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tian Y et al. (2026). Semaglutide targets muscle mitochondria to regulate glutamine metabolism and treat… [PMID: 42305583]
Laboratory literature summary: Semaglutide targets muscle mitochondria to regulate glutamine metabolism and treat osteoarthritis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li T et al. (2025). Semaglutide and the Eyes-A Literature Glut, but Little Clarity [PMID: 40810949]
Laboratory literature summary: Semaglutide and the Eyes-A Literature Glut, but Little Clarity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Channabasappa S et al. (2026). Atypical retrobulbar optic neuropathy after semaglutide escalation [PMID: 42220603]
Laboratory literature summary: Atypical retrobulbar optic neuropathy after semaglutide escalation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2025). Semaglutide Eases Knee Osteoarthritis Pain in People With metabolic research models [PMID: 39641950]
Laboratory literature summary: Semaglutide Eases Knee Osteoarthritis Pain in People With metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khan U (2025). Laboratory research record on GLP-1S [PMID: 40500852]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hausner H et al. (2017). Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and… [PMID: 28349387]
Laboratory literature summary: Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zweck E et al. (2019). Laboratory research record on GLP-1S [PMID: 31747739]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Harris E (2024). EHR Data Suggest Tirzepatide Outdoes Semaglutide for body-composition research [PMID: 39093576]
Laboratory literature summary: EHR Data Suggest Tirzepatide Outdoes Semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chaudhry A et al. (2024). Tendency of Semaglutide to Induce Gastroparesis: A Case Report [PMID: 38371020]
Laboratory literature summary: Tendency of Semaglutide to Induce Gastroparesis: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kmietowicz Z (2023). Sixty seconds on… the cost of semaglutide [PMID: 37652469]
Laboratory literature summary: Sixty seconds on… the cost of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fujino E et al. (2023). Anesthesia Considerations for a research subjects on Semaglutide and Delayed Gastric… [PMID: 37602101]
Laboratory literature summary: Anesthesia Considerations for a research subjects on Semaglutide and Delayed Gastric Emptying. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hamley IW et al. (2025). Semaglutide Aggregates into Oligomeric Micelles and Short Fibrils in Aqueous Solution [PMID: 40355389]
Laboratory literature summary: Semaglutide Aggregates into Oligomeric Micelles and Short Fibrils in Aqueous Solution. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mann JFE et al. (2021). Potential kidney protection with liraglutide and semaglutide: Exploratory mediation… [PMID: 34009708]
Laboratory literature summary: Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vishwanath C et al. (2026). Toxicity of Semaglutide upon sub chronic administration in Rabbits [PMID: 41503438]
Laboratory literature summary: Toxicity of Semaglutide upon sub chronic administration in Rabbits. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Elliott DC et al. (2026). Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report [PMID: 41658769]
Laboratory literature summary: Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Santos LB et al. (2024). A call to update anesthetic protocols: the hidden risks of semaglutide [PMID: 38807009]
Laboratory literature summary: A call to update anesthetic protocols: the hidden risks of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Menzen M et al. (2023). Laboratory research record on GLP-1S [PMID: 36599459]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Farooqi MF et al. (2025). Portal vein thrombosis in a research subjects on semaglutide [PMID: 40792243]
Laboratory literature summary: Portal vein thrombosis in a research subjects on semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ayoub I et al. (2025). Semaglutide and kidney function: direct kidney protection or an artifact? [PMID: 39566843]
Laboratory literature summary: Semaglutide and kidney function: direct kidney protection or an artifact?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gragnano F et al. (2024). FLOW trial stopped early due to evidence of renal protection with semaglutide [PMID: 37934595]
Laboratory literature summary: FLOW trial stopped early due to evidence of renal protection with semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Arbouche N et al. (2024). Semaglutide and health risk: Development and validation of a LC-HRMS method for… [PMID: 38880054]
Laboratory literature summary: Semaglutide and health risk: Development and validation of a LC-HRMS method for testing semaglutide in whole blood and application to…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lewis AL et al. (2022). Development and approval of rybelsus (oral semaglutide): ushering in a new era in… [PMID: 34024013]
Laboratory literature summary: Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pacheco AP (2025). Laboratory research record on GLP-1S [PMID: 40991735]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Husain M et al. (2019). Laboratory research record on GLP-1S [PMID: 31747740]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lu M (2026). Angiogenesis and inflammation in the retinopathy risk of insulin and semaglutide – a… [PMID: 41851808]
Laboratory literature summary: Angiogenesis and inflammation in the retinopathy risk of insulin and semaglutide – a review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sattar N et al. (2025). Semaglutide 7·2 mg: another step towards tackling diseases mediated by metabolic… [PMID: 40961951]
Laboratory literature summary: Semaglutide 7·2 mg: another step towards tackling diseases mediated by metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bernardo ME et al. (2026). Laboratory research record on GLP-1S [PMID: 41768861]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Jiesisibieke ZL et al. (2025). Has the "metabolic research models paradox" been resolved by semaglutide trials? [PMID: 40184017]
Laboratory literature summary: Has the "metabolic research models paradox" been resolved by semaglutide trials?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shamsulddin AB (2025). Laboratory research record on GLP-1S [PMID: 40796132]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Gandhi GY (2021). Laboratory research record on GLP-1S [PMID: 34724396]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Zhu J et al. (2025). High-exposure level Semaglutide: Balancing Marginal Glycemic Benefits With… [PMID: 41115224]
Laboratory literature summary: High-exposure level Semaglutide: Balancing Marginal Glycemic Benefits With Tolerability Trade-Offs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lichtenstein GR (2025). Examining the Use of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis [PMID: 40115606]
Laboratory literature summary: Examining the Use of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schianchi A et al. (2026). Can semaglutide influence oncology research models biomarkers? Insight from a… [PMID: 42485519]
Laboratory literature summary: Can semaglutide influence oncology research models biomarkers? Insight from a laboratory case. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ingwiller M (2025). Clarifying the interpretation of semaglutide's impact in the FLOW study [PMID: 40254368]
Laboratory literature summary: Clarifying the interpretation of semaglutide's impact in the FLOW study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Eisner K et al. (2026). Laboratory research record on GLP-1S [PMID: 42314683]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Castrillon F et al. (2025). Laboratory research record on GLP-1S [PMID: 40988574]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Papaetis GS et al. (2026). Semaglutide and Alcohol use Disorder: Breaking Free of Addiction? [PMID: 41937527]
Laboratory literature summary: Semaglutide and Alcohol use Disorder: Breaking Free of Addiction?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Noreña JA et al. (2025). Comparison of Fracture Risk Following Semaglutide investigation vs Sleeve Gastrectomy [PMID: 41467149]
Laboratory literature summary: Comparison of Fracture Risk Following Semaglutide investigation vs Sleeve Gastrectomy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shen MY et al. (2025). Strategies for improving research on semaglutide in cocaine use disorder [PMID: 40865350]
Laboratory literature summary: Strategies for improving research on semaglutide in cocaine use disorder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yahya R et al. (2026). Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate [PMID: 42397155]
Laboratory literature summary: Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mangalesh S et al. (2026). Semaglutide, body-composition research, and cardiovascular outcomes in the SELECT trial [PMID: 42035776]
Laboratory literature summary: Semaglutide, body-composition research, and cardiovascular outcomes in the SELECT trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tondt J et al. (2026). Semaglutide, body-composition research, and cardiovascular outcomes in the SELECT trial [PMID: 42035775]
Laboratory literature summary: Semaglutide, body-composition research, and cardiovascular outcomes in the SELECT trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Deanfield J (2025). Effects of semaglutide on heart failure outcomes – Author's reply [PMID: 39955114]
Laboratory literature summary: Effects of semaglutide on heart failure outcomes – Author's reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gu GH et al. (2025). Association of semaglutide with retained gastric contents on endoscopy: Retrospective… [PMID: 40230563]
Laboratory literature summary: Association of semaglutide with retained gastric contents on endoscopy: Retrospective analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mosqueira A et al. (2026). Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice [PMID: 42436546]
Laboratory literature summary: Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2025). Study Finds Modest Link Between Semaglutide and a Type of Vision Impairment [PMID: 40053340]
Laboratory literature summary: Study Finds Modest Link Between Semaglutide and a Type of Vision Impairment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Antonacci G et al. (2025). Hypoglycaemic coma induced by a falsified semaglutide product: a case report [PMID: 41125326]
Laboratory literature summary: Hypoglycaemic coma induced by a falsified semaglutide product: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Odenwald MA et al. (2026). Practical Considerations for the Use of Semaglutide in MASH [PMID: 41128632]
Laboratory literature summary: Practical Considerations for the Use of Semaglutide in MASH. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Huynh K (2025). Expanding cardiovascular indications for semaglutide: results from the SOUL and STRIDE… [PMID: 40229511]
Laboratory literature summary: Expanding cardiovascular indications for semaglutide: results from the SOUL and STRIDE trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Van Boxel E et al. (2025). What should I consider when prescribing semaglutide for children living with metabolic… [PMID: 39242181]
Laboratory literature summary: What should I consider when prescribing semaglutide for children living with metabolic research models?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shahabian L et al. (2026). Semaglutide Selectively Improves Metabolic and Cognitive Function in 5xFAD Mice [PMID: 42353032]
Laboratory literature summary: Semaglutide Selectively Improves Metabolic and Cognitive Function in 5xFAD Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lang K (2025). Laboratory research record on GLP-1S [PMID: 39900371]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Samajdar SS et al. (2026). Semaglutide beyond body-composition research: Mechanistic insights and functional… [PMID: 41145354]
Laboratory literature summary: Semaglutide beyond body-composition research: Mechanistic insights and functional paradoxes from the SEMALEAN study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wilson AQ et al. (2026). Readability and understandability of online research subjects education on semaglutide [PMID: 41877445]
Laboratory literature summary: Readability and understandability of online research subjects education on semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang IG et al. (2025). Laboratory research record on GLP-1S [PMID: 41003035]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dusetzina SB et al. (2026). Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements [PMID: 41926100]
Laboratory literature summary: Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alorfi NM et al. (2026). Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports [PMID: 42152320]
Laboratory literature summary: Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Murugadoss K et al. (2026). Semaglutide cardiovascular outcomes align more closely with attained exposure level… [PMID: 42432224]
Laboratory literature summary: Semaglutide cardiovascular outcomes align more closely with attained exposure level than achieved body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kahwaji J et al. (2025). Laboratory profile and observed endpoints of Liraglutide and Semaglutide in Kidney… [PMID: 39847451]
Laboratory literature summary: laboratory profile and observed endpoints of Liraglutide and Semaglutide in Kidney Transplant Recipients. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Moreno-Borque R et al. (2024). Delayed Type Hypersensitivity Reaction Induced By Liraglutide With Tolerance to… [PMID: 38911363]
Laboratory literature summary: Delayed Type Hypersensitivity Reaction Induced By Liraglutide With Tolerance to Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Salter A et al. (2026). Use of semaglutide and tirzepatide among people with multiple sclerosis [PMID: 42053291]
Laboratory literature summary: Use of semaglutide and tirzepatide among people with multiple sclerosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kishimori T et al. (2025). Laboratory research record on GLP-1S [PMID: 40826494]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Tu SS et al. (2026). Early Generic Semaglutide in Canada-Implications for US research subjects and Policy [PMID: 42258199]
Laboratory literature summary: Early Generic Semaglutide in Canada-Implications for US research subjects and Policy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Momeni P et al. (2026). Topic and Sentiment Trends in Semaglutide Discussions on X: Subpopulation-Based… [PMID: 41734897]
Laboratory literature summary: Topic and Sentiment Trends in Semaglutide Discussions on X: Subpopulation-Based Longitudinal Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Samajdar SS et al. (2026). Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in… [PMID: 42256584]
Laboratory literature summary: Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xu R (2025). Response to the letter titled "Analysis of semaglutide's effect on neurodegeneration… [PMID: 39807703]
Laboratory literature summary: Response to the letter titled "Analysis of semaglutide's effect on neurodegeneration research models's disease risk". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sherwin M et al. (2023). Influence of semaglutide use on the presence of residual gastric solids on gastric… [PMID: 37466909]
Laboratory literature summary: Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Manoharan SVRR et al. (2024). Laboratory research record on GLP-1S [PMID: 38938530]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Nogrady B (2026). The 'astounding' rise of semaglutide – and what's next for body-composition research drugs [PMID: 41680520]
Laboratory literature summary: The 'astounding' rise of semaglutide – and what's next for body-composition research drugs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shamsulddin A (2025). Oral Formulation and SGLT2i Interaction: Key Nuances in Semaglutide's Effect on Atrial… [PMID: 40327546]
Laboratory literature summary: Oral Formulation and SGLT2i Interaction: Key Nuances in Semaglutide's Effect on Atrial Fibrillation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li L et al. (2026). Evaluating Semaglutide's Protection in H/R – Injured AC16 Cardiomyocytes: Oxidative… [PMID: 41737537]
Laboratory literature summary: Evaluating Semaglutide's Protection in H/R – Injured AC16 Cardiomyocytes: Oxidative Stress, Inflammation, Apoptosis, and Autophagy Insights. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Martin S et al. (2024). [Does a higher exposure level of oral semaglutide investigation make sense?] [PMID: 38214721]
Laboratory literature summary: [Does a higher exposure level of oral semaglutide investigation make sense?]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Verma S et al. (2025). Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide [PMID: 39673759]
Laboratory literature summary: Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2025). Laboratory research record on GLP-1S [PMID: 39919809]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Chen H et al. (2025). The investigational Effects of Semaglutide in Congenital Linear Scleroderma [PMID: 40861533]
Laboratory literature summary: The investigational Effects of Semaglutide in Congenital Linear Scleroderma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gionfriddo MR et al. (2025). An analysis of national news coverage of semaglutide for body-composition research [PMID: 39580054]
Laboratory literature summary: An analysis of national news coverage of semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2026). Correction to: "Atypical retrobulbar optic neuropathy after semaglutide escalation" [PMID: 42440707]
Laboratory literature summary: Correction to: "Atypical retrobulbar optic neuropathy after semaglutide escalation". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khan S et al. (2026). Pharmacological progress in metabolic research models: tirzepatide's rising advantage… [PMID: 41497097]
Laboratory literature summary: Pharmacological progress in metabolic research models: tirzepatide's rising advantage over semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Timms M et al. (2026). Identification of semaglutide use through detection of U6 and U7 metabolites in… [PMID: 41364333]
Laboratory literature summary: Identification of semaglutide use through detection of U6 and U7 metabolites in research subjects urine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cesaro A et al. (2025). Reply to "Oral Formulation and SGLT2i Interaction: Key Nuances in Semaglutide's Effect… [PMID: 40386908]
Laboratory literature summary: Reply to "Oral Formulation and SGLT2i Interaction: Key Nuances in Semaglutide's Effect on Atrial Fibrillation". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Taşkaldıran I et al. (2026). Glycaemic changes during early semaglutide investigation: a case of pancreatic… [PMID: 42171706]
Laboratory literature summary: Glycaemic changes during early semaglutide investigation: a case of pancreatic adenocarcinoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tayyaba S et al. (2026). Laboratory research record on GLP-1S [PMID: 41675811]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (2026). Laboratory research record on GLP-1S [PMID: 41566767]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Author et al. (2026). Laboratory research record on GLP-1S [PMID: 42068314]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Klemets A et al. (2026). Fecal microbiome predicts investigation response after the initiation of semaglutide… [PMID: 41580554]
Laboratory literature summary: Fecal microbiome predicts investigation response after the initiation of semaglutide or empagliflozin uptake. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frant J (2026). Rewriting the will: Autonomy and pharmacological desire modification in semaglutide use [PMID: 41033788]
Laboratory literature summary: Rewriting the will: Autonomy and pharmacological desire modification in semaglutide use. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shannon K et al. (2025). Laboratory research record on GLP-1S [PMID: 39438027]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hamal S et al. (2020). Laboratory research record on GLP-1S [PMID: 32271261]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Laugsand SS et al. (2026). Remission of erythromelalgia after semaglutide initiation: A case report [PMID: 42088719]
Laboratory literature summary: Remission of erythromelalgia after semaglutide initiation: A case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alzahrani WS et al. (2025). Alopecia areata following semaglutide investigation for body-composition research: A… [PMID: 40787040]
Laboratory literature summary: Alopecia areata following semaglutide investigation for body-composition research: A case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kozato A et al. (2026). Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide [PMID: 42467193]
Laboratory literature summary: Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stark M et al. (2026). Pleural and Pericardial Effusions Associated with Semaglutide: A Case Report [PMID: 41666880]
Laboratory literature summary: Pleural and Pericardial Effusions Associated with Semaglutide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kennis VCW et al. (2026). SemaGBA: A System Dynamics Model of the Semaglutide-Responsive Gut-Brain Axis A Model… [PMID: 41969210]
Laboratory literature summary: SemaGBA: A System Dynamics Model of the Semaglutide-Responsive Gut-Brain Axis A Model of How the Brain and Semaglutide Regulate feeding-behavior endpoints…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kraft BD et al. (2026). Angioedema After Accidental Semaglutide exposure design Error: A Case Report [PMID: 42194666]
Laboratory literature summary: Angioedema After Accidental Semaglutide exposure design Error: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ragozzino G et al. (2026). Comment on Shah and Ayala. Interpreting Stage-Dependent Changes in Semaglutide… [PMID: 42160524]
Laboratory literature summary: Comment on Shah and Ayala. Interpreting Stage-Dependent Changes in Semaglutide Response: From Patterns to Mechanisms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Quarenghi M et al. (2026). Prolonged Dysesthesia After Massive Accidental Semaglutide Overdose: A Case Report [PMID: 42256775]
Laboratory literature summary: Prolonged Dysesthesia After Massive Accidental Semaglutide Overdose: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li H et al. (2026). Observed endpoints of semaglutide in IgA nephropathy with metabolic research models: a… [PMID: 41629851]
Laboratory literature summary: observed endpoints of semaglutide in IgA nephropathy with metabolic research models: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Osorio Borjas M et al. (2025). Echoes of Dormancy: Anomic Aphasia Unveils Neurocysticercosis Reactivation in a… [PMID: 40407613]
Laboratory literature summary: Echoes of Dormancy: Anomic Aphasia Unveils Neurocysticercosis Reactivation in a research subjects on Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sterckx M et al. (2026). Euglycemic Ketoacidosis Following the Use of Counterfeit Semaglutide for… [PMID: 41773123]
Laboratory literature summary: Euglycemic Ketoacidosis Following the Use of Counterfeit Semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Burson JR et al. (2026). Lithium toxicity following a change from semaglutide to tirzepatide for… [PMID: 41646202]
Laboratory literature summary: Lithium toxicity following a change from semaglutide to tirzepatide for body-composition research management. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Eliaschewitz FG et al. (2021). Advances in GLP-1 investigation: focus on oral semaglutide [PMID: 34526121]
Laboratory literature summary: Advances in GLP-1 investigation: focus on oral semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lake JE et al. (2026). Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study [PMID: 42517548]
Laboratory literature summary: Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Urias E et al. (2024). PNPLA3 Risk Allele Association With ALT Response to Semaglutide investigation [PMID: 37972824]
Laboratory literature summary: PNPLA3 Risk Allele Association With ALT Response to Semaglutide investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Frías JP et al. (2022). Laboratory research record on GLP-1S [PMID: 35172067]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Williams DM et al. (2020). Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies [PMID: 32880877]
Laboratory literature summary: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Coon SA et al. (2018). Semaglutide once-weekly: improved observed endpoints with a new laboratory profile warning [PMID: 30296182]
Laboratory literature summary: Semaglutide once-weekly: improved observed endpoints with a new laboratory profile warning. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bock A (2024). Study: Semaglutide Lowered Chronic Kidney Disease-Related Risks [PMID: 38904969]
Laboratory literature summary: Study: Semaglutide Lowered Chronic Kidney Disease-Related Risks. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tamayo-Trujillo R et al. (2024). Molecular mechanisms of semaglutide and liraglutide as a investigational option for… [PMID: 38742021]
Laboratory literature summary: Molecular mechanisms of semaglutide and liraglutide as a investigational option for metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lingvay I et al. (2020). Cardiovascular outcomes, laboratory profile, and tolerability with oral semaglutide:… [PMID: 33439583]
Laboratory literature summary: Cardiovascular outcomes, laboratory profile, and tolerability with oral semaglutide: insights for managed care. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Granhall C et al. (2018). Pharmacokinetics, laboratory profile and Tolerability of Oral Semaglutide in Subjects… [PMID: 29623579]
Laboratory literature summary: Pharmacokinetics, laboratory profile and Tolerability of Oral Semaglutide in Subjects with Renal Impairment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Geiger N et al. (2026). PYY(3-36) potentiates Semaglutide‑mediated mitochondrial modulation in MASLD [PMID: 42526426]
Laboratory literature summary: PYY(3-36) potentiates Semaglutide‑mediated mitochondrial modulation in MASLD. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nejat C et al. (2026). Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A… [PMID: 42487660]
Laboratory literature summary: Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Olowo-Oribi BA et al. (2025). Laboratory research record on GLP-1S [PMID: 40583149]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Mathur V et al. (2025). Neoadjuvant Semaglutide, Bariatric Surgery body-composition research, and Overall Outcomes [PMID: 40042864]
Laboratory literature summary: Neoadjuvant Semaglutide, Bariatric Surgery body-composition research, and Overall Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iacobellis G et al. (2025). How Semaglutide Effects on Epicardial Fat Inflammation Can Be Good for the Heart [PMID: 39779063]
Laboratory literature summary: How Semaglutide Effects on Epicardial Fat Inflammation Can Be Good for the Heart. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cool D et al. (2024). Laboratory research record on GLP-1S [PMID: 39691771]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
da Hora Passos R et al. (2024). Laboratory research record on GLP-1S [PMID: 39504528]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Diab H et al. (2024). Laboratory research record on GLP-1S [PMID: 39275201]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Agra de Melo Junior C et al. (2024). Exocrine Pancreatic Insufficiency During the Use of Semaglutide: A Case Report [PMID: 38576650]
Laboratory literature summary: Exocrine Pancreatic Insufficiency During the Use of Semaglutide: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zeng H et al. (2024). Effect of hydroxyethyl starch on drug stability and release of semaglutide in PLGA… [PMID: 38471578]
Laboratory literature summary: Effect of hydroxyethyl starch on drug stability and release of semaglutide in PLGA microspheres. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liuzzo G et al. (2024). Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few [PMID: 38103177]
Laboratory literature summary: Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Haidar L et al. (2024). Body-composition research associated with semaglutide investigation among people with HIV [PMID: 37976053]
Laboratory literature summary: body-composition research associated with semaglutide investigation among people with HIV. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Murugadoss K et al. (2026). Laboratory research record on GLP-1S [PMID: 42163990]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Zeng J et al. (2026). Quality and Reliability of Semaglutide-Related Short Videos on TikTok and Bilibili [PMID: 42077173]
Laboratory literature summary: Quality and Reliability of Semaglutide-Related Short Videos on TikTok and Bilibili. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mullard A (2025). Lilly's tirzepatide and Novo Nordisk's semaglutide vie for top drug spot [PMID: 41199002]
Laboratory literature summary: Lilly's tirzepatide and Novo Nordisk's semaglutide vie for top drug spot. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gasoyan H et al. (2025). Reasons for Discontinuation of metabolic research models Pharmacotherapy With… [PMID: 41039650]
Laboratory literature summary: Reasons for Discontinuation of metabolic research models Pharmacotherapy With Semaglutide or Tirzepatide in laboratory Practice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bowie K (2025). Semaglutide: FDA approves body-composition research jab to treat severe liver disease [PMID: 40841128]
Laboratory literature summary: Semaglutide: FDA approves body-composition research jab to treat severe liver disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Catalán V et al. (2025). Oral semaglutide in HFpEF: Real-world evidence and causal considerations [PMID: 40716975]
Laboratory literature summary: Oral semaglutide in HFpEF: Real-world evidence and causal considerations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sokary S et al. (2025). Exploring beyond numeric body-composition research: The metabolic effects of semaglutide [PMID: 40107359]
Laboratory literature summary: Exploring beyond numeric body-composition research: The metabolic effects of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ashraf AR et al. (2024). Laboratory research record on GLP-1S [PMID: 39093567]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Ragsdale LB et al. (2024). Plastic surgery amid a semaglutide epidemic: Direction for future studies and service… [PMID: 38889587]
Laboratory literature summary: Plastic surgery amid a semaglutide epidemic: Direction for future studies and service implications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yaribeygi H et al. (2024). Anti-inflammatory benefits of semaglutide: State of the art [PMID: 38576822]
Laboratory literature summary: Anti-inflammatory benefits of semaglutide: State of the art. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wackerhage H et al. (2024). Turning fat into muscle: can this be an alternative to anti-metabolic research models… [PMID: 38426245]
Laboratory literature summary: Turning fat into muscle: can this be an alternative to anti-metabolic research models drugs such as semaglutide?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bhateja A et al. (2023). Semaglutide in NASH-related cirrhosis: still a long way to go? [PMID: 37453428]
Laboratory literature summary: Semaglutide in NASH-related cirrhosis: still a long way to go?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sharma A et al. (2022). Laboratory research record on GLP-1S [PMID: 34373613]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Gunning K (2020). Oral Semaglutide: Balancing Promising Therapeutics with Adverse Effects and Access… [PMID: 32857647]
Laboratory literature summary: Oral Semaglutide: Balancing Promising Therapeutics with Adverse Effects and Access Barriers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Baekdal TA et al. (2018). Pharmacokinetics, laboratory profile, and Tolerability of Oral Semaglutide in Subjects… [PMID: 29693715]
Laboratory literature summary: Pharmacokinetics, laboratory profile, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Holst JJ et al. (2017). Semaglutide seems to be more effective the other GLP-1Ras [PMID: 29299466]
Laboratory literature summary: Semaglutide seems to be more effective the other GLP-1Ras. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Islam RK et al. (2026). A-MACE-Ing: A Real-World Analysis of Semaglutide's Impact on Major Adverse… [PMID: 40928108]
Laboratory literature summary: A-MACE-Ing: A Real-World Analysis of Semaglutide's Impact on Major Adverse Cardiovascular Events (MACE) in research subjects With…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sabbagh M et al. (2025). Laboratory profile considerations of semaglutide in the potential investigation of… [PMID: 40337158]
Laboratory literature summary: laboratory profile considerations of semaglutide in the potential investigation of neurodegeneration research models's disease: A pooled…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ojinna BT et al. (2026). Laboratory research record on GLP-1S [PMID: 42220771]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Smolderen KG et al. (2025). Laboratory research record on GLP-1S [PMID: 40926360]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Yu Y et al. (2026). Gestational Weight Gain and developmental research context Outcomes After Semaglutide… [PMID: 42208070]
Laboratory literature summary: Gestational Weight Gain and developmental research context Outcomes After Semaglutide Exposure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tuttle KR et al. (2026). Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial [PMID: 41706532]
Laboratory literature summary: Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zacharia GS et al. (2025). Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis: A Narrative Review [PMID: 41322896]
Laboratory literature summary: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis: A Narrative Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Joseph J (2025). The Impact of Semaglutide on Metabolic Syndrome: A Case Report [PMID: 40755669]
Laboratory literature summary: The Impact of Semaglutide on Metabolic Syndrome: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brand K et al. (2025). Semaglutide reverses the chronic myopathy of hyperkalemic periodic paralysis: a case… [PMID: 40197299]
Laboratory literature summary: Semaglutide reverses the chronic myopathy of hyperkalemic periodic paralysis: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Si FL et al. (2025). Laboratory research record on GLP-1S [PMID: 40159445]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lakshmanan S et al. (2025). Reply: How Semaglutide Effects on Epicardial Fat Inflammation Can Be Good for the Heart [PMID: 39779064]
Laboratory literature summary: Reply: How Semaglutide Effects on Epicardial Fat Inflammation Can Be Good for the Heart. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shetty NP et al. (2024). Acute generalized exanthematous pustulosis sine pustules following semaglutide… [PMID: 39345280]
Laboratory literature summary: Acute generalized exanthematous pustulosis sine pustules following semaglutide parenteral-route administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hejdak D et al. (2024). Interaction of Semaglutide and Ziprasidone in a research subjects With Schizophrenia:… [PMID: 38817502]
Laboratory literature summary: Interaction of Semaglutide and Ziprasidone in a research subjects With Schizophrenia: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mao T et al. (2024). Semaglutide alters gut microbiota and improves NAFLD in db/db mice [PMID: 38583231]
Laboratory literature summary: Semaglutide alters gut microbiota and improves NAFLD in db/db mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khoo TK et al. (2021). Laboratory research record on GLP-1S [PMID: 34192447]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Maggioni AP et al. (2026). From evidence to practice: Identifying candidates for semaglutide in chronic… [PMID: 42361988]
Laboratory literature summary: From evidence to practice: Identifying candidates for semaglutide in chronic atherosclerotic disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vitorino R (2026). The systems medicine view of semaglutide: from laboratory trials to molecular mechanisms [PMID: 42339860]
Laboratory literature summary: The systems medicine view of semaglutide: from laboratory trials to molecular mechanisms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Diebold J et al. (2026). Spontaneous Pneumomediastinum Associated with Semaglutide research protocol: A Case Report [PMID: 42291462]
Laboratory literature summary: Spontaneous Pneumomediastinum Associated with Semaglutide research protocol: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Qaseem M et al. (2026). Semaglutide-induced lean mass loss: laboratory concern or physiological adaptation [PMID: 42254092]
Laboratory literature summary: Semaglutide-induced lean mass loss: laboratory concern or physiological adaptation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aljabri AA (2026). Semaglutide in Metabolic Medicine: A Review on laboratory Applications and Emerging… [PMID: 42237968]
Laboratory literature summary: Semaglutide in Metabolic Medicine: A Review on laboratory Applications and Emerging Therapeutics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang W et al. (2026). Correction: Semaglutide Mitigates Ischemic Brain Injury by Inhibiting Ferroptosis via… [PMID: 41996021]
Laboratory literature summary: Correction: Semaglutide Mitigates Ischemic Brain Injury by Inhibiting Ferroptosis via Modulation of FoXO1 and DRP1 Pathways. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Corley M et al. (2025). Epigenetic Aging and investigation Response to Semaglutide in the SLIM LIVER Study [PMID: 41256006]
Laboratory literature summary: Epigenetic Aging and investigation Response to Semaglutide in the SLIM LIVER Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim C et al. (2025). Semaglutide and Tirzepatide Prescribing for metabolic research models in research… [PMID: 41196576]
Laboratory literature summary: Semaglutide and Tirzepatide Prescribing for metabolic research models in research subjects With Preexisting Comorbid Cancers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Agarwal PN et al. (2025). Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics… [PMID: 40686549]
Laboratory literature summary: Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics simulations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Giordani I et al. (2025). Letter: Amiodarone-Induced Thyrotoxicosis Following Semaglutide-Associated… [PMID: 40470537]
Laboratory literature summary: Letter: Amiodarone-Induced Thyrotoxicosis Following Semaglutide-Associated body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2025). Semaglutide Improves Severe Liver Disease in Phase 3 Trial [PMID: 40408124]
Laboratory literature summary: Semaglutide Improves Severe Liver Disease in Phase 3 Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li Y et al. (2024). Sodium glycocholate liposome encapsulated semaglutide increases oral bioavailability… [PMID: 39244070]
Laboratory literature summary: Sodium glycocholate liposome encapsulated semaglutide increases oral bioavailability by promoting intestinal absorption. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lusk JB et al. (2024). Cardiovascular event reduction among a US population eligible for semaglutide per the… [PMID: 39182939]
Laboratory literature summary: Cardiovascular event reduction among a US population eligible for semaglutide per the SELECT trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Oskinis S et al. (2024). Could semaglutide be related to increasing the risk of developing a disordered eating? [PMID: 38311483]
Laboratory literature summary: Could semaglutide be related to increasing the risk of developing a disordered eating?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gallwitz B et al. (2021). Laboratory research record on GLP-1S [PMID: 34267725]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Nadolsky KZ et al. (2021). Laboratory research record on GLP-1S [PMID: 34192448]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Javor E et al. (2021). Laboratory research record on GLP-1S [PMID: 34192446]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Wilding JPH et al. (2021). Laboratory research record on GLP-1S [PMID: 33567185]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Holst JJ et al. (2018). Erratum to semaglutide seems to be more effective the other GLP-1Ras [PMID: 29611550]
Laboratory literature summary: Erratum to semaglutide seems to be more effective the other GLP-1Ras. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Guimarães GNF (2026). Transient Hyperprolactinemia Associated With Semaglutide in a research subjects With… [PMID: 42211780]
Laboratory literature summary: Transient Hyperprolactinemia Associated With Semaglutide in a research subjects With Hashimoto's Thyroiditis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dziewierz A et al. (2026). Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for… [PMID: 41075125]
Laboratory literature summary: Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational Data. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bouhajib M et al. (2025). Laboratory research record on GLP-1S [PMID: 40425315]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Greenberg NR et al. (2025). A Case of Semaglutide-Induced Euphoria in a research subjects With Bipolar Disorder [PMID: 39999771]
Laboratory literature summary: A Case of Semaglutide-Induced Euphoria in a research subjects With Bipolar Disorder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Martens MD et al. (2024). Laboratory research record on GLP-1S [PMID: 39822607]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Posada Posada MI et al. (2025). Laboratory research record on GLP-1S [PMID: 39425524]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Rivera FB et al. (2024). Evaluating the laboratory profile profile of semaglutide: an updated meta-analysis [PMID: 39046272]
Laboratory literature summary: Evaluating the laboratory profile profile of semaglutide: an updated meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Brown C (2023). High price and demand for semaglutide means lack of access for US research subjects [PMID: 37648269]
Laboratory literature summary: High price and demand for semaglutide means lack of access for US research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Polyzos SA et al. (2022). Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that… [PMID: 35668318]
Laboratory literature summary: Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hedrington MS et al. (2019). Laboratory research record on GLP-1S [PMID: 30499733]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Mohapatra D (2026). Affordable Semaglutide in India: Expanding Access and Unanswered Questions for… [PMID: 42474946]
Laboratory literature summary: Affordable Semaglutide in India: Expanding Access and Unanswered Questions for Children and Special Populations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dong Y (2026). Laboratory research record on GLP-1S [PMID: 42453931]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Spitery A et al. (2026). Laboratory research record on GLP-1S [PMID: 42335260]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Shah H et al. (2026). Response to Comment on Shah and Ayala. Interpreting Stage-Dependent Changes in… [PMID: 42160528]
Laboratory literature summary: Response to Comment on Shah and Ayala. Interpreting Stage-Dependent Changes in Semaglutide Response: From Patterns to Mechanisms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yuan Y et al. (2026). Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice [PMID: 42126676]
Laboratory literature summary: Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kofman K et al. (2026). Oral Health Considerations and Dental Management Guidelines for Semaglutide Medications [PMID: 41967795]
Laboratory literature summary: Oral Health Considerations and Dental Management Guidelines for Semaglutide Medications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Castelletto V et al. (2026). Fibrillar and Micellar Aggregation of Semaglutide and Formation of a Chiral-Imprinted… [PMID: 41917693]
Laboratory literature summary: Fibrillar and Micellar Aggregation of Semaglutide and Formation of a Chiral-Imprinted Glass. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nikolaeva A et al. (2025). Subocclusive ileus following non-approved investigational high-exposure level semaglutide use [PMID: 41294925]
Laboratory literature summary: Subocclusive ileus following non-approved investigational high-exposure level semaglutide use. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tourtourikov I et al. (2026). Laboratory research record on GLP-1S [PMID: 40996853]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Butt JH et al. (2025). Frailty and Semaglutide in metabolic research models-Related HFpEF: Another STEP in… [PMID: 40884983]
Laboratory literature summary: Frailty and Semaglutide in metabolic research models-Related HFpEF: Another STEP in the Right Direction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nishida K et al. (2025). Psychiatric and psychological adverse effects associated with dulaglutide,… [PMID: 40617160]
Laboratory literature summary: Psychiatric and psychological adverse effects associated with dulaglutide, semaglutide, and liraglutide: A vigibase study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nemlekar PM et al. (2025). Combined effect of continuous glucose monitoring and semaglutide: analysis of… [PMID: 40227398]
Laboratory literature summary: Combined effect of continuous glucose monitoring and semaglutide: analysis of administrative claims. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2025). FDA Approves Semaglutide to Reduce Risk of Kidney Disease Progression [PMID: 40019747]
Laboratory literature summary: FDA Approves Semaglutide to Reduce Risk of Kidney Disease Progression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bahdi F et al. (2025). Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for… [PMID: 39909715]
Laboratory literature summary: Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Author et al. (2024). Phase 3 ESSENCE Trial: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis [PMID: 39896971]
Laboratory literature summary: Phase 3 ESSENCE Trial: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Perkovic V et al. (2024). Laboratory research record on GLP-1S [PMID: 39504529]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Alkhalifah M et al. (2024). Semaglutide for the management of diabesity: The real-world experience [PMID: 39310241]
Laboratory literature summary: Semaglutide for the management of diabesity: The real-world experience. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tavosanis A (2024). Laboratory research record on GLP-1S [PMID: 39196229]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Magruder ML et al. (2024). Semaglutide and Other GLP-1 Agonists: A Boon for the Arthroplasty Industry? [PMID: 38182322]
Laboratory literature summary: Semaglutide and Other GLP-1 Agonists: A Boon for the Arthroplasty Industry?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang W et al. (2023). Semaglutide Pretreatment Induces Cardiac Autophagy to Reduce Myocardial Injury in… [PMID: 37811623]
Laboratory literature summary: Semaglutide Pretreatment Induces Cardiac Autophagy to Reduce Myocardial Injury in Septic Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li JR et al. (2023). Case Report: Semaglutide-associated depression: a report of two cases [PMID: 37706035]
Laboratory literature summary: Case Report: Semaglutide-associated depression: a report of two cases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tiba AT et al. (2023). Semaglutide in renal ischemia-reperfusion injury in mice [PMID: 36937464]
Laboratory literature summary: Semaglutide in renal ischemia-reperfusion injury in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Srivastava G et al. (2021). Laboratory research record on GLP-1S [PMID: 34192449]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Horii T et al. (2024). Adherence and investigation discontinuation of oral semaglutide and once-weekly… [PMID: 39243175]
Laboratory literature summary: Adherence and investigation discontinuation of oral semaglutide and once-weekly semaglutide parenteral-route administration at 12 month…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ghusn W et al. (2026). Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for metabolic… [PMID: 42383938]
Laboratory literature summary: Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for metabolic research models: A Multicentered Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Balboa Ramilo A et al. (2026). Semaglutide Prevents Aortic Rupture and Dissection in the Angiotensin II Mouse Model [PMID: 42072473]
Laboratory literature summary: Semaglutide Prevents Aortic Rupture and Dissection in the Angiotensin II Mouse Model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rout S et al. (2026). Research models are protected from semaglutide-induced muscle loss in ob/ob mice [PMID: 41867824]
Laboratory literature summary: research models are protected from semaglutide-induced muscle loss in ob/ob mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hasse L et al. (2026). Laboratory research record on GLP-1S [PMID: 41738100]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Ullah H et al. (2026). RETRACTION: Comparative observed endpoints of semaglutide versus liraglutide on… [PMID: 41532579]
Laboratory literature summary: RETRACTION: Comparative observed endpoints of semaglutide versus liraglutide on body-composition research and glycaemic control. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chen PH et al. (2026). Effects of semaglutide on vessel morphology: Studies on the chicken chorioallantoic… [PMID: 41125168]
Laboratory literature summary: Effects of semaglutide on vessel morphology: Studies on the chicken chorioallantoic membrane. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Betensky DJ et al. (2025). The Cost-Effectiveness of Semaglutide and Tirzepatide for research subjects With Knee… [PMID: 40953447]
Laboratory literature summary: The Cost-Effectiveness of Semaglutide and Tirzepatide for research subjects With Knee Osteoarthritis and metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shah VN et al. (2025). Laboratory research record on GLP-1S [PMID: 40550013]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Fiore A et al. (2024). Observed endpoints of Semaglutide in Reactive Hypoglycemia Related to Dumping Syndrome… [PMID: 39041260]
Laboratory literature summary: observed endpoints of Semaglutide in Reactive Hypoglycemia Related to Dumping Syndrome after Bariatric Surgery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sciacovelli C et al. (2023). Semaglutide for investigating metabolic research models Induced by Craniopharyngioma… [PMID: 37908981]
Laboratory literature summary: Semaglutide for investigating metabolic research models Induced by Craniopharyngioma Resection: A Successful Case Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Magruder ML et al. (2023). Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty? [PMID: 37279843]
Laboratory literature summary: Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wilding JPH et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1… [PMID: 35441470]
Laboratory literature summary: Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rosen CJ et al. (2021). Laboratory research record on GLP-1S [PMID: 34192451]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Niman S et al. (2021). A Review on the observed endpoints and laboratory profile of Oral Semaglutide [PMID: 33772451]
Laboratory literature summary: A Review on the observed endpoints and laboratory profile of Oral Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Williams DM et al. (2021). Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies [PMID: 33417153]
Laboratory literature summary: Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Matza LS et al. (2020). Assessing research subjects PREFERence between the dulaglutide pen and the semaglutide… [PMID: 31646727]
Laboratory literature summary: Assessing research subjects PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Madsbad S et al. (2017). Laboratory research record on GLP-1S [PMID: 28385658]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Xiao S et al. (2026). Laboratory research record on GLP-1S [PMID: 41793524]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Serafini A et al. (2026). [Semaglutide is laboratory profile and effective for prediabetes and metabolic… [PMID: 41716099]
Laboratory literature summary: [Semaglutide is laboratory profile and effective for prediabetes and metabolic research models in research subjects with schizofrenia.]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Karthikeyan H et al. (2025). Laboratory research record on GLP-1S [PMID: 40908778]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Parker AE (2025). Laboratory research record on GLP-1S [PMID: 40729307]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lin HT et al. (2025). Laboratory research record on GLP-1S [PMID: 40663350]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Quarenghi M et al. (2025). Laboratory research record on GLP-1S [PMID: 40507553]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Sanyal AJ et al. (2025). Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis [PMID: 40305708]
Laboratory literature summary: Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu B et al. (2025). Knowledge, attitude and practice toward liraglutide and semaglutide among… [PMID: 40185826]
Laboratory literature summary: Knowledge, attitude and practice toward liraglutide and semaglutide among endocrinology medical staff. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lee SO et al. (2024). Laboratory research record on GLP-1S [PMID: 39594606]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Schneider EL et al. (2024). The limitation of lipidation: Conversion of semaglutide from once-weekly to… [PMID: 39531496]
Laboratory literature summary: The limitation of lipidation: Conversion of semaglutide from once-weekly to once-monthly exposure design. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Collister D et al. (2024). In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y [PMID: 39222509]
Laboratory literature summary: In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bracha P et al. (2024). Reversible bilateral central scotoma under scotopic conditions associated with oral… [PMID: 39175932]
Laboratory literature summary: Reversible bilateral central scotoma under scotopic conditions associated with oral semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schoretsanitis G et al. (2024). Disproportionality Analysis From World Health Organization Data on Semaglutide,… [PMID: 39163046]
Laboratory literature summary: Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rodriguez PJ et al. (2024). Laboratory research record on GLP-1S [PMID: 38976257]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Yuan D (2024). A review regarding the article 'Semaglutide and heart failure: Updated meta-analysis [PMID: 38944224]
Laboratory literature summary: A review regarding the article 'Semaglutide and heart failure: Updated meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lunati ME et al. (2024). Laboratory research record on GLP-1S [PMID: 38128857]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Amaro A et al. (2022). Laboratory research record on GLP-1S [PMID: 36691309]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Liu DX et al. (2022). Semaglutide Protects against 6-OHDA Toxicity by Enhancing Autophagy and Inhibiting… [PMID: 35873704]
Laboratory literature summary: Semaglutide Protects against 6-OHDA Toxicity by Enhancing Autophagy and Inhibiting Oxidative Stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vilsbøll T et al. (2018). Laboratory research record on GLP-1S [PMID: 29178519]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Schacht JP et al. (2026). Laboratory research record on GLP-1S [PMID: 42522065]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Inia JA et al. (2026). Semaglutide and Exercise Synergy in metabolic research models: Preserving Muscle Mass… [PMID: 42449565]
Laboratory literature summary: Semaglutide and Exercise Synergy in metabolic research models: Preserving Muscle Mass and Uncovering Organ Crosstalk. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xu K et al. (2026). Revision Medialization Thyroplasty for Glottic Insufficiency Amid Rapid… [PMID: 42439301]
Laboratory literature summary: Revision Medialization Thyroplasty for Glottic Insufficiency Amid Rapid body-composition research on Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Eun Y et al. (2026). Semaglutide and Risk of Adult-Onset Seizure: A Target Trial Emulation [PMID: 42308439]
Laboratory literature summary: Semaglutide and Risk of Adult-Onset Seizure: A Target Trial Emulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Biasin M et al. (2026). Use of semaglutide after acute coronary syndrome: an exploratory retrospective study [PMID: 41703411]
Laboratory literature summary: Use of semaglutide after acute coronary syndrome: an exploratory retrospective study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Farahvash A et al. (2025). Laboratory research record on GLP-1S [PMID: 40562647]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Diec CB et al. (2026). Laboratory research record on GLP-1S [PMID: 40232990]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hulst AH et al. (2025). Residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound [PMID: 39635940]
Laboratory literature summary: Residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kushner RF et al. (2024). Response to "The laboratory profile of semaglutide in research subjects with… [PMID: 39497516]
Laboratory literature summary: Response to "The laboratory profile of semaglutide in research subjects with depression and metabolic research models". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gasoyan H et al. (2024). Laboratory research record on GLP-1S [PMID: 39269703]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Feng J et al. (2024). Laboratory research record on GLP-1S [PMID: 39148685]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Ditzenberger GL et al. (2025). Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study [PMID: 39046173]
Laboratory literature summary: Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pinto S et al. (2024). Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular… [PMID: 38215986]
Laboratory literature summary: Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mares AC et al. (2022). Laboratory research record on GLP-1S [PMID: 35175229]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Wilding JPH et al. (2021). Laboratory research record on GLP-1S [PMID: 34192450]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Røder ME (2019). Laboratory research record on GLP-1S [PMID: 31844422]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Teli B et al. (2026). Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and… [PMID: 42311743]
Laboratory literature summary: Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and laboratory Outcomes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ullah H et al. (2026). RETRACTION: Comparative observed endpoints of semaglutide versus liraglutide on… [PMID: 41932355]
Laboratory literature summary: RETRACTION: Comparative observed endpoints of semaglutide versus liraglutide on body-composition research and glycaemic control. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lešin Gaćina D et al. (2025). Is Semaglutide Linked to NAION? A Case Report on a Rare Ocular Complication [PMID: 40843891]
Laboratory literature summary: Is Semaglutide Linked to NAION? A Case Report on a Rare Ocular Complication. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Qi L et al. (2025). Laboratory research record on GLP-1S [PMID: 40413074]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Widera E (2025). Falsification periods seen with an immediate reduction in neurodegeneration research… [PMID: 40364443]
Laboratory literature summary: Falsification periods seen with an immediate reduction in neurodegeneration research models's disease with semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xu Q et al. (2025). The Impact of Semaglutide on Cardiac Mass and Function Requires Further Investigation [PMID: 40306860]
Laboratory literature summary: The Impact of Semaglutide on Cardiac Mass and Function Requires Further Investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Di Odoardo LAF et al. (2025). Metabolic research models update: cardiovascular risk and investigational innovations… [PMID: 40248309]
Laboratory literature summary: metabolic research models update: cardiovascular risk and investigational innovations (focus on semaglutide and tirzepatide). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Scheen A et al. (2024). [New outcome studies with parenteral-route administration semaglutide in different at… [PMID: 39397557]
Laboratory literature summary: [New outcome studies with parenteral-route administration semaglutide in different at risk populations]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Masson W et al. (2024). Acute pancreatitis due to different semaglutide regimens: An updated meta-analysis [PMID: 38555109]
Laboratory literature summary: Acute pancreatitis due to different semaglutide regimens: An updated meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Irfan H (2024). Metabolic research models, Cardiovascular Disease, and the Promising Role of… [PMID: 37640171]
Laboratory literature summary: metabolic research models, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chow KW et al. (2024). Semaglutide is effective in achieving body-composition research in liver transplant… [PMID: 37639288]
Laboratory literature summary: Semaglutide is effective in achieving body-composition research in liver transplant recipients. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
O'Neil PM et al. (2022). Exploring the wider benefits of semaglutide investigation in metabolic research… [PMID: 36691307]
Laboratory literature summary: Exploring the wider benefits of semaglutide investigation in metabolic research models: insight from the STEP program. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pan X et al. (2022). Laboratory research record on GLP-1S [PMID: 35843090]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Xiu X et al. (2026). A systematic review of semaglutide-associated kidney injury case reports [PMID: 42305970]
Laboratory literature summary: A systematic review of semaglutide-associated kidney injury case reports. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Corley MJ et al. (2026). Laboratory research record on GLP-1S [PMID: 42156721]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dziewierz A et al. (2026). Semaglutide in Frail HFpEF: Need for Objective Functional Measures and Body… [PMID: 41951288]
Laboratory literature summary: Semaglutide in Frail HFpEF: Need for Objective Functional Measures and Body Composition Assessment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Luo Y et al. (2026). Development of an electrochemiluminescence immunoassay for quantitative determination… [PMID: 41871707]
Laboratory literature summary: Development of an electrochemiluminescence immunoassay for quantitative determination of semaglutide in research subjects serum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wise J (2026). Laboratory research record on GLP-1S [PMID: 41760125]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Alnima T et al. (2026). Laboratory research record on GLP-1S [PMID: 41654369]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Windram M et al. (2026). Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of… [PMID: 40699363]
Laboratory literature summary: Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in research models and research models rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Massy M et al. (2025). Increased vision impairment reports linked to semaglutide: analysis of FDA adverse… [PMID: 40189538]
Laboratory literature summary: Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sattar S et al. (2025). Making semaglutide accessible in Pakistan: A crucial step for heart failure investigation [PMID: 39948813]
Laboratory literature summary: Making semaglutide accessible in Pakistan: A crucial step for heart failure investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Phillips MJ et al. (2025). Recurrent Idiopathic Intracranial Hypertension-Related Papilledema After Abrupt… [PMID: 39905586]
Laboratory literature summary: Recurrent Idiopathic Intracranial Hypertension-Related Papilledema After Abrupt Discontinuation of Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rennert-May E et al. (2025). Cost-Effectiveness of Semaglutide in research subjects With metabolic research models… [PMID: 39772331]
Laboratory literature summary: Cost-Effectiveness of Semaglutide in research subjects With metabolic research models and Cardiovascular Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lin K et al. (2025). Laboratory research record on GLP-1S [PMID: 39710830]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lewis JE et al. (2025). Semaglutide and Postoperative Outcomes in Nondiabetic research subjects Following Body… [PMID: 39665435]
Laboratory literature summary: Semaglutide and Postoperative Outcomes in Nondiabetic research subjects Following Body Contouring Surgery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ortiz GU et al. (2024). Semaglutide as a possible research protocol for healthy aging: Targeting the hallmarks… [PMID: 39547367]
Laboratory literature summary: Semaglutide as a possible research protocol for healthy aging: Targeting the hallmarks of aging. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Feldman-Billard S (2024). Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic… [PMID: 39480455]
Laboratory literature summary: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim DW et al. (2024). Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic… [PMID: 39480405]
Laboratory literature summary: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khaskheli SA et al. (2024). Semaglutide: An emerging investigation option for research subjects with metabolic… [PMID: 39279100]
Laboratory literature summary: Semaglutide: An emerging investigation option for research subjects with metabolic research models related HFpEF. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dobson R (2024). Semaglutide and research subjects Receiving Hemodialysis: Case Reports of Unexpected… [PMID: 38720915]
Laboratory literature summary: Semaglutide and research subjects Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
García-Vega D et al. (2024). Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with… [PMID: 38172989]
Laboratory literature summary: Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Harris E (2023). Laboratory research record on GLP-1S [PMID: 37728959]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Loomba R et al. (2023). Semaglutide in NASH-related cirrhosis: still a long way to go? – Authors' reply [PMID: 37453429]
Laboratory literature summary: Semaglutide in NASH-related cirrhosis: still a long way to go? – Authors' reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ebell MH (2023). Laboratory research record on GLP-1S [PMID: 37440751]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lau DCW et al. (2022). Laboratory research record on GLP-1S [PMID: 35466848]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Villela R et al. (2022). Laboratory research record on GLP-1S [PMID: 34949728]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Isaacs DM et al. (2021). Optimizing investigational Outcomes With Oral Semaglutide: A research… [PMID: 33627989]
Laboratory literature summary: Optimizing investigational Outcomes With Oral Semaglutide: A research subjects-Centered Approach. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Boroghină SC et al. (2026). Beyond body-composition research: Early Real-World Evidence of Semaglutide in… [PMID: 42496290]
Laboratory literature summary: Beyond body-composition research: Early Real-World Evidence of Semaglutide in metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li Z et al. (2026). Post-sleeve gastrectomy body-composition research: Role of botulinum toxin and… [PMID: 41777326]
Laboratory literature summary: Post-sleeve gastrectomy body-composition research: Role of botulinum toxin and semaglutide parenteral-route administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu Q et al. (2026). Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between… [PMID: 41771053]
Laboratory literature summary: Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lo SC Sr et al. (2026). Acute Pancreatitis Associated With Semaglutide in a research subjects With… [PMID: 41728571]
Laboratory literature summary: Acute Pancreatitis Associated With Semaglutide in a research subjects With Multimorbidity: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Herrera HO et al. (2026). Risk of new-onset hair loss with semaglutide and tirzepatide: A TriNetX cohort study [PMID: 41707704]
Laboratory literature summary: Risk of new-onset hair loss with semaglutide and tirzepatide: A TriNetX cohort study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Iftikhar P et al. (2025). Assessing the laboratory profile of Semaglutide and Tirzepatide in Black and Asian… [PMID: 40755607]
Laboratory literature summary: Assessing the laboratory profile of Semaglutide and Tirzepatide in Black and Asian Populations: A Narrative Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gasoyan H et al. (2025). Changes in weight and glycemic control following metabolic research models… [PMID: 40491239]
Laboratory literature summary: Changes in weight and glycemic control following metabolic research models investigation with semaglutide or tirzepatide by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
MacIsaac RJ (2025). Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome [PMID: 40458885]
Laboratory literature summary: Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Funderburg NT et al. (2025). The Effects of Semaglutide on Inflammation and Immune Activation in HIV-associated… [PMID: 40160348]
Laboratory literature summary: The Effects of Semaglutide on Inflammation and Immune Activation in HIV-associated Lipohypertrophy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vitorino R (2025). Exploring omics signature in the cardiovascular response to semaglutide: Mechanistic… [PMID: 39400314]
Laboratory literature summary: Exploring omics signature in the cardiovascular response to semaglutide: Mechanistic insights and laboratory implications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Queiroz VNF et al. (2025). Evaluation of gastric content in fasting research subjects during semaglutide use: an… [PMID: 39343660]
Laboratory literature summary: Evaluation of gastric content in fasting research subjects during semaglutide use: an observational study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Svendstrup M et al. (2024). Semaglutide investigation of hypothalamic metabolic research models – a real-life data… [PMID: 39120810]
Laboratory literature summary: Semaglutide investigation of hypothalamic metabolic research models – a real-life data study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Overgaard RV et al. (2021). Laboratory Pharmacokinetics of Oral Semaglutide: Analyses of Data from laboratory… [PMID: 33969456]
Laboratory literature summary: laboratory Pharmacokinetics of Oral Semaglutide: Analyses of Data from laboratory Pharmacology Trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Levi J et al. (2026). How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications… [PMID: 42437874]
Laboratory literature summary: How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim DH et al. (2026). Formulation Engineering of Oral Semaglutide Tablets: Unleashing Gastric Intestinal… [PMID: 42357295]
Laboratory literature summary: Formulation Engineering of Oral Semaglutide Tablets: Unleashing Gastric Intestinal Permeation with Sodium Caprate. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Heerspink HJL et al. (2026). Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the… [PMID: 42308057]
Laboratory literature summary: Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zinzi A et al. (2026). Unmasking counterfeit semaglutide: analysis of real-world laboratory profile data from… [PMID: 42137313]
Laboratory literature summary: Unmasking counterfeit semaglutide: analysis of real-world laboratory profile data from EudraVigilance. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Russo S et al. (2026). Endoluminal device induces insulin sensitivity and greater weight control than… [PMID: 42120185]
Laboratory literature summary: Endoluminal device induces insulin sensitivity and greater weight control than semaglutide in pigs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hussein MH et al. (2026). Response To "Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A… [PMID: 41317265]
Laboratory literature summary: Response To "Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sun M et al. (2026). Semaglutide and colorectal tumors: methodological pitfalls and translational gaps -… [PMID: 41202322]
Laboratory literature summary: Semaglutide and colorectal tumors: methodological pitfalls and translational gaps – Letter to the Editor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Barrado-Ballestero S et al. (2026). Deep learning-enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis [PMID: 41121520]
Laboratory literature summary: Deep learning-enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Heald AH et al. (2025). Metabolic research models and Schizophrenia: Results of a Feasibility Study with… [PMID: 40536760]
Laboratory literature summary: metabolic research models and Schizophrenia: Results of a Feasibility Study with Semaglutide to Assist body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kassir R et al. (2025). Discontinuation of Tirzepatide and Semaglutide Prior to Gastric Sleeve Surgery:… [PMID: 40163291]
Laboratory literature summary: Discontinuation of Tirzepatide and Semaglutide Prior to Gastric Sleeve Surgery: laboratory Considerations and Guidelines. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shabto JM et al. (2025). Central Retinal Artery Occlusion With Cilioretinal Artery Sparing After Semaglutide… [PMID: 39928352]
Laboratory literature summary: Central Retinal Artery Occlusion With Cilioretinal Artery Sparing After Semaglutide parenteral-route administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yang Y et al. (2025). Laboratory research record on GLP-1S [PMID: 39886945]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dürschmied D et al. (2025). [Semaglutide for heart failure with preserved ejection fraction] [PMID: 39820736]
Laboratory literature summary: [Semaglutide for heart failure with preserved ejection fraction]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Maro JC et al. (2024). Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic… [PMID: 39480446]
Laboratory literature summary: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Etminan M et al. (2024). Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic… [PMID: 39480440]
Laboratory literature summary: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cui QN (2024). Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic… [PMID: 39480409]
Laboratory literature summary: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lusk JB et al. (2024). Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic… [PMID: 39480407]
Laboratory literature summary: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sciscent BY et al. (2025). Laboratory research record on GLP-1S [PMID: 39056124]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Olatunji G et al. (2024). Can Semaglutide offer hope for research subjects with metabolic research… [PMID: 38871039]
Laboratory literature summary: Can Semaglutide offer hope for research subjects with metabolic research models-related heart failure?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alsugair HA et al. (2021). Weekly Semaglutide vs. Liraglutide observed endpoints Profile: A Network Meta-Analysis [PMID: 34574899]
Laboratory literature summary: Weekly Semaglutide vs. Liraglutide observed endpoints Profile: A Network Meta-Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gao C et al. (2026). Semaglutide drives body-composition research through cAMP-dependent mechanisms in… [PMID: 42174184]
Laboratory literature summary: Semaglutide drives body-composition research through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Deanfield J et al. (2026). Semaglutide, body-composition research, and cardiovascular outcomes in the SELECT… [PMID: 42035774]
Laboratory literature summary: Semaglutide, body-composition research, and cardiovascular outcomes in the SELECT trial – Authors' reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu J et al. (2026). Semaglutide attenuates autistic-like behaviors in BTBR mice through the shaping of gut… [PMID: 41724218]
Laboratory literature summary: Semaglutide attenuates autistic-like behaviors in BTBR mice through the shaping of gut microbiota. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu Y et al. (2026). Skeletal effect of semaglutide and tirzepatide in research subjects with increased… [PMID: 41655226]
Laboratory literature summary: Skeletal effect of semaglutide and tirzepatide in research subjects with increased risk of fractures. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kaur RJ et al. (2026). Disproportionality analysis of semaglutide-associated bile-duct oncology research… [PMID: 41639322]
Laboratory literature summary: Disproportionality analysis of semaglutide-associated bile-duct oncology research models: A vigibase study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mondoh A et al. (2025). Tirzepatide vs. semaglutide: laboratory decision-making in the GLP-1 landscape [PMID: 41351384]
Laboratory literature summary: Tirzepatide vs. semaglutide: laboratory decision-making in the GLP-1 landscape. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Russo S et al. (2025). ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut… [PMID: 41025205]
Laboratory literature summary: ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cesaro A et al. (2025). Weight for rhythm: is the evidence for atrial fibrillation risk with semaglutide still… [PMID: 40855814]
Laboratory literature summary: Weight for rhythm: is the evidence for atrial fibrillation risk with semaglutide still premature?: reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Samuels JM et al. (2025). Real-world titration, persistence & body-composition research of semaglutide and… [PMID: 40762026]
Laboratory literature summary: Real-world titration, persistence & body-composition research of semaglutide and tirzepatide in an academic metabolic research models clinic. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Corbalan JJ et al. (2025). The inhibitor VB-87531 synergizes with tirzepatide and semaglutide for greater… [PMID: 40694906]
Laboratory literature summary: The inhibitor VB-87531 synergizes with tirzepatide and semaglutide for greater body-composition research in DIO mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xie JS et al. (2024). Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic… [PMID: 39480447]
Laboratory literature summary: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li X et al. (2024). Semaglutide attenuates doxorubicin-induced cardiotoxicity by ameliorating… [PMID: 38574433]
Laboratory literature summary: Semaglutide attenuates doxorubicin-induced cardiotoxicity by ameliorating BNIP3-Mediated mitochondrial dysfunction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hepprich M et al. (2021). Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study [PMID: 33615400]
Laboratory literature summary: Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chang YF et al. (2020). Semaglutide-mediated protection against Aβ correlated with enhancement of autophagy… [PMID: 33222922]
Laboratory literature summary: Semaglutide-mediated protection against Aβ correlated with enhancement of autophagy and inhibition of apotosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Fazioli KT et al. (2020). Laboratory research record on GLP-1S [PMID: 32857658]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hedrington MS et al. (2018). Laboratory research record on GLP-1S [PMID: 29431519]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Davies M et al. (2017). Laboratory research record on GLP-1S [PMID: 29049653]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Fouad Y et al. (2026). Resmetirom and semaglutide research protocol for research subjects with MAFLD in the… [PMID: 42397248]
Laboratory literature summary: Resmetirom and semaglutide research protocol for research subjects with MAFLD in the MENA region: expert panel recommendations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Anderer S (2026). Oral Semaglutide Sustains Long-Term CVD Risk Factor Reductions [PMID: 42030062]
Laboratory literature summary: Oral Semaglutide Sustains Long-Term CVD Risk Factor Reductions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cong Y et al. (2026). Metabolite Profiling and Identification of Semaglutide in Liver S9 Across Species and… [PMID: 41787929]
Laboratory literature summary: Metabolite Profiling and Identification of Semaglutide in Liver S9 Across Species and Rat Plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dauleh H et al. (2025). Observed endpoints of Semaglutide in Pediatric research subjects With Bardet-Biedl… [PMID: 41312179]
Laboratory literature summary: observed endpoints of Semaglutide in Pediatric research subjects With Bardet-Biedl Syndrome and Alström Syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Salah HM et al. (2025). Semaglutide in Peripheral Artery Disease: A Step Toward Sex-Specific Care [PMID: 41224404]
Laboratory literature summary: Semaglutide in Peripheral Artery Disease: A Step Toward Sex-Specific Care. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Malgave A et al. (2025). Influence of Buffering Capacity, pH, and Temperature on the Stability of Semaglutide:… [PMID: 40635175]
Laboratory literature summary: Influence of Buffering Capacity, pH, and Temperature on the Stability of Semaglutide: A Preformulation Study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yaghmayee S et al. (2025). Neuroprotective and cognitive benefits of Semaglutide: Insights into the underlying… [PMID: 40494410]
Laboratory literature summary: Neuroprotective and cognitive benefits of Semaglutide: Insights into the underlying molecular mechanisms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mohamad AA (2025). A case report of semaglutide induced sarcopenia: causes of fatigue in older adults [PMID: 40223309]
Laboratory literature summary: A case report of semaglutide induced sarcopenia: causes of fatigue in older adults. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nguyen JT et al. (2024). Semaglutide investigation in a research subjects with Extreme metabolic research… [PMID: 39250902]
Laboratory literature summary: Semaglutide investigation in a research subjects with Extreme metabolic research models and Massive Lymphedema: A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Martini E (2023). Laboratory research record on GLP-1S [PMID: 39196255]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Welk B et al. (2024). Laboratory research record on GLP-1S [PMID: 38860419]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Petrie MC et al. (2024). Semaglutide and NT-proBNP in metabolic research models-Related HFpEF: Insights From… [PMID: 38819334]
Laboratory literature summary: Semaglutide and NT-proBNP in metabolic research models-Related HFpEF: Insights From the STEP-HFpEF Program. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nagendra L et al. (2023). Semaglutide and oncology research models: A systematic review and meta-analysis [PMID: 37531876]
Laboratory literature summary: Semaglutide and oncology research models: A systematic review and meta-analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Klein SR et al. (2023). Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case… [PMID: 36977934]
Laboratory literature summary: Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jensen JK et al. (2022). Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of… [PMID: 35400496]
Laboratory literature summary: Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ciconte G et al. (2026). Semaglutide as adjunctive research protocol to catheter ablation in metabolic research… [PMID: 41666150]
Laboratory literature summary: Semaglutide as adjunctive research protocol to catheter ablation in metabolic research models-related paroxysmal atrial fibrillation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vaidya V et al. (2026). Laboratory research record on GLP-1S [PMID: 41437637]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Yang T et al. (2025). Optic disc edema during semaglutide research protocol: case report and literature review [PMID: 41311659]
Laboratory literature summary: Optic disc edema during semaglutide research protocol: case report and literature review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nagib N et al. (2025). Weighing the Risks: Small Bowel Obstruction Associated With Semaglutide Use in the… [PMID: 40861748]
Laboratory literature summary: Weighing the Risks: Small Bowel Obstruction Associated With Semaglutide Use in the Postoperative Abdomen. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu Y et al. (2026). Molecular dynamics insights into the binding interactions of semaglutide with research… [PMID: 40720332]
Laboratory literature summary: Molecular dynamics insights into the binding interactions of semaglutide with research subjects serum albumin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tejera-Pérez C (2025). Laboratory research record on GLP-1S [PMID: 40540673]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Kenzheshova A et al. (2025). Neuroprotective Role of the Novel GLP-1R Agonist Semaglutide [PMID: 40277068]
Laboratory literature summary: Neuroprotective Role of the Novel GLP-1R Agonist Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Razavi AC et al. (2025). Laboratory research record on GLP-1S [PMID: 39797878]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Singh AK et al. (2024). Nonarteritic Anterior Ischemic Optic Neuropathy and Semaglutide: What is This All About? [PMID: 39163055]
Laboratory literature summary: Nonarteritic Anterior Ischemic Optic Neuropathy and Semaglutide: What is This All About?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Petralli G et al. (2024). Laboratory research record on GLP-1S [PMID: 38760852]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Almutair A et al. (2024). Semaglutide as a potential investigational alternative for HNF1B-MODY: a case study [PMID: 38524636]
Laboratory literature summary: Semaglutide as a potential investigational alternative for HNF1B-MODY: a case study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mellbin LG et al. (2024). Laboratory research record on GLP-1S [PMID: 38416593]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lambson JE et al. (2023). Laboratory research record on GLP-1S [PMID: 37392810]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Heile M et al. (2020). Laboratory research record on GLP-1S [PMID: 33439580]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Bækdal TA et al. (2019). Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin,… [PMID: 30945118]
Laboratory literature summary: Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bækdal TA et al. (2018). Laboratory research record on GLP-1S [PMID: 29897249]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Pandey A et al. (2026). Reply: Semaglutide in Frail HFpEF: Need for Objective Functional Measures and Body… [PMID: 41951287]
Laboratory literature summary: Reply: Semaglutide in Frail HFpEF: Need for Objective Functional Measures and Body Composition Assessment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chen M et al. (2026). Beyond research subjects Factors: Are we Missing the Surgical Context in Comparing… [PMID: 41801639]
Laboratory literature summary: Beyond research subjects Factors: Are we Missing the Surgical Context in Comparing Tirzepatide and Semaglutide Post-CABG?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lam B et al. (2026). Immune-mediated necrotising myopathy following semaglutide investigation: a… [PMID: 41786442]
Laboratory literature summary: Immune-mediated necrotising myopathy following semaglutide investigation: a contributing factor?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Finze A et al. (2026). Laboratory research record on GLP-1S [PMID: 41575550]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Abuetabh Y et al. (2025). Reply: The Impact of Semaglutide on Cardiac Mass and Function Requires Further… [PMID: 40306861]
Laboratory literature summary: Reply: The Impact of Semaglutide on Cardiac Mass and Function Requires Further Investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lee KJ et al. (2025). Preparation and investigational Evaluation of Engineered Semaglutide and Statin-Lipid… [PMID: 40284475]
Laboratory literature summary: Preparation and investigational Evaluation of Engineered Semaglutide and Statin-Lipid Conjugate-Based Nanoparticle. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hwang JH et al. (2025). Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults [PMID: 40085108]
Laboratory literature summary: Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ammon JP et al. (2024). Laboratory research record on GLP-1S [PMID: 39047253]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Withaar C et al. (2023). The Cardioprotective Effects of Semaglutide Exceed Those of Dietary body-composition… [PMID: 38094687]
Laboratory literature summary: The Cardioprotective Effects of Semaglutide Exceed Those of Dietary body-composition research in Mice With HFpEF. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gulak MA et al. (2023). Regurgitation under anesthesia in a fasted research subjects prescribed semaglutide… [PMID: 37280458]
Laboratory literature summary: Regurgitation under anesthesia in a fasted research subjects prescribed semaglutide for body-composition research: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Keating SK et al. (2023). Semaglutide and social media: implications for young research subjects with polycystic… [PMID: 36803633]
Laboratory literature summary: Semaglutide and social media: implications for young research subjects with polycystic ovarian syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rajput R et al. (2022). First-in-Class Oral Semaglutide: Overcoming Barriers of Incretinisation in the Indian… [PMID: 36618518]
Laboratory literature summary: First-in-Class Oral Semaglutide: Overcoming Barriers of Incretinisation in the Indian Context. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Formoso G et al. (2022). Semaglutide in routine laboratory practice: interesting news from real-world evidence [PMID: 35524036]
Laboratory literature summary: Semaglutide in routine laboratory practice: interesting news from real-world evidence. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Miles KE et al. (2018). Laboratory research record on GLP-1S [PMID: 34861016]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Buse JB et al. (2026). Laboratory research record on GLP-1S [PMID: 42251859]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Khanna A et al. (2026). Laboratory research record on GLP-1S [PMID: 42060800]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Qin H et al. (2026). Semaglutide ameliorates osteoarthritis progression through a body-composition… [PMID: 41666927]
Laboratory literature summary: Semaglutide ameliorates osteoarthritis progression through a body-composition research-independent metabolic restoration mechanism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vlaeminck N et al. (2026). Gastric ultrasound in research subjects receiving semaglutide: a prospective,… [PMID: 41631344]
Laboratory literature summary: Gastric ultrasound in research subjects receiving semaglutide: a prospective, multicentre, matched control study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Barrea L et al. (2025). A Multidisciplinary Perspective on Semaglutide investigation and Medical Nutrition… [PMID: 41129057]
Laboratory literature summary: A Multidisciplinary Perspective on Semaglutide investigation and Medical Nutrition research protocol in metabolic research models Management. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Liu X et al. (2025). Coverage and Prior Authorization Policies for Semaglutide and Tirzepatide in Medicare… [PMID: 40880091]
Laboratory literature summary: Coverage and Prior Authorization Policies for Semaglutide and Tirzepatide in Medicare Part D Plans. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xu R (2025). Response to the letter titled "Targeting dementia prevention with semaglutide: the… [PMID: 40572020]
Laboratory literature summary: Response to the letter titled "Targeting dementia prevention with semaglutide: the case for APOE4 homozygotes". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kovvuru K et al. (2025). Minimal Change Podocytopathy with Coexistent Thin Glomerular Basement Membrane… [PMID: 40035048]
Laboratory literature summary: Minimal Change Podocytopathy with Coexistent Thin Glomerular Basement Membrane following Exposure to Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kotwal SS et al. (2025). Laboratory research record on GLP-1S [PMID: 39990872]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lv F et al. (2024). Laboratory research record on GLP-1S [PMID: 39770498]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Shapira-Furman T et al. (2024). The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of… [PMID: 39202988]
Laboratory literature summary: The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wagner J (2024). Laboratory research record on GLP-1S [PMID: 39047252]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Cohen C et al. (2024). Laboratory research record on GLP-1S [PMID: 39047251]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
HamaSalih RM (2024). Effects of Semaglutide in Doxorubicin-Induced Cardiac Toxicity in Wistar Albino Rats [PMID: 38952352]
Laboratory literature summary: Effects of Semaglutide in Doxorubicin-Induced Cardiac Toxicity in Wistar Albino Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Okada S et al. (2024). Hot Water Eliminates the Bitter Taste of Oral Semaglutide: A Report of Four Cases [PMID: 38220187]
Laboratory literature summary: Hot Water Eliminates the Bitter Taste of Oral Semaglutide: A Report of Four Cases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wang W et al. (2024). Association of semaglutide with risk of suicidal ideation in a real-world cohort [PMID: 38182782]
Laboratory literature summary: Association of semaglutide with risk of suicidal ideation in a real-world cohort. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dicker D et al. (2023). Laboratory research record on GLP-1S [PMID: 37846993]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Azuri J et al. (2023). Laboratory research record on GLP-1S [PMID: 37203328]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Pan X et al. (2022). Laboratory research record on GLP-1S [PMID: 36452054]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Noda K et al. (2022). Laboratory research record on GLP-1S [PMID: 36117924]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Tariq MA et al. (2022). Laboratory research record on GLP-1S [PMID: 35985949]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
McLean BA et al. (2021). Differential importance of endothelial and hematopoietic cell GLP-1Rs for… [PMID: 34673572]
Laboratory literature summary: Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Xiong S et al. (2024). Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World… [PMID: 38776037]
Laboratory literature summary: Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rout S et al. (2026). Research models Are Completely Resistant to Semaglutide-Induced Muscle Loss in ob/ob Mice [PMID: 42390988]
Laboratory literature summary: research models Are Completely Resistant to Semaglutide-Induced Muscle Loss in ob/ob Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lau D et al. (2026). In T2D inadequately controlled with metformin, orforglipron reduced HbA(1c) more than… [PMID: 42224699]
Laboratory literature summary: In T2D inadequately controlled with metformin, orforglipron reduced HbA(1c) more than oral semaglutide at 52 wk. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Corley MJ et al. (2026). Pilot study of epigenetic aging and investigation response to semaglutide in the SLIM… [PMID: 42014432]
Laboratory literature summary: Pilot study of epigenetic aging and investigation response to semaglutide in the SLIM LIVER study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sullivan SD et al. (2026). Reestimation of Medicare Spending for Semaglutide After Most Favored Nation and… [PMID: 41651376]
Laboratory literature summary: Reestimation of Medicare Spending for Semaglutide After Most Favored Nation and Medicare Drug Price Negotiation Announcements. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Velasco Á et al. (2026). Research subjects after acute myocardial infarction: potential of semaglutide in… [PMID: 41520703]
Laboratory literature summary: research subjects after acute myocardial infarction: potential of semaglutide in prognosis for reducing events and mortality. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Inoue K et al. (2025). Laboratory research record on GLP-1S [PMID: 40991302]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Verma S et al. (2025). Sex Differences in Effectiveness of Semaglutide in research subjects With Peripheral… [PMID: 40892617]
Laboratory literature summary: Sex Differences in Effectiveness of Semaglutide in research subjects With Peripheral Artery Disease: The STRIDE Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li Y et al. (2025). Laboratory research record on GLP-1S [PMID: 40493329]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Avignon A et al. (2025). Clustering of intuitive eating and psychological health identifies subgroups… [PMID: 40177856]
Laboratory literature summary: Clustering of intuitive eating and psychological health identifies subgroups associated with body-composition research following semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McEwan P et al. (2025). Laboratory research record on GLP-1S [PMID: 39882599]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Orrange S et al. (2025). Laboratory research record on GLP-1S [PMID: 39655368]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Kosiborod MN et al. (2024). Laboratory research record on GLP-1S [PMID: 39047254]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hansen MK et al. (2024). Laboratory research record on GLP-1S [PMID: 38418010]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Deng Y et al. (2022). Laboratory research record on GLP-1S [PMID: 35813188]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Yang X et al. (2021). Laboratory research record on GLP-1S [PMID: 33417950]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Brunton SA et al. (2020). Integrating oral semaglutide into laboratory practice in primary care: for whom, when,… [PMID: 32815453]
Laboratory literature summary: Integrating oral semaglutide into laboratory practice in primary care: for whom, when, and how?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mehta J et al. (2026). Acute Systemic Complications Following High-exposure level Semaglutide Reinitiation in… [PMID: 42038657]
Laboratory literature summary: Acute Systemic Complications Following High-exposure level Semaglutide Reinitiation in an Elderly research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hajibandeh S et al. (2026). Semaglutide for metabolic research models management: A narrative review of observed… [PMID: 42025961]
Laboratory literature summary: Semaglutide for metabolic research models management: A narrative review of observed endpoints, laboratory profile, and future directions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gong H et al. (2026). Semaglutide investigation reverses HFD induced hippocampal microglia activation and… [PMID: 41916100]
Laboratory literature summary: Semaglutide investigation reverses HFD induced hippocampal microglia activation and improves cognitive dysfunction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Whorton A et al. (2025). Prescribing Patterns and Adverse Effects of Semaglutide: A Real-World Comparative… [PMID: 41516966]
Laboratory literature summary: Prescribing Patterns and Adverse Effects of Semaglutide: A Real-World Comparative Evaluation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Escolà-Rodríguez A et al. (2025). Semaglutide-associated psychiatric disorders: A case report and literature review [PMID: 41173570]
Laboratory literature summary: Semaglutide-associated psychiatric disorders: A case report and literature review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mademlis C et al. (2025). Semaglutide for the investigation of MASH: reaching into the ESSENCE of… [PMID: 41070406]
Laboratory literature summary: Semaglutide for the investigation of MASH: reaching into the ESSENCE of cardio-metabolic health?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Borlaug BA et al. (2025). Semaglutide and Exercise Function in metabolic research models-Related HFpEF: Insights… [PMID: 41045908]
Laboratory literature summary: Semaglutide and Exercise Function in metabolic research models-Related HFpEF: Insights From the STEP-HFpEF Program. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Luna-Ceron E et al. (2025). Laboratory research record on GLP-1S [PMID: 40798974]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Li W et al. (2025). Laboratory research record on GLP-1S [PMID: 40126828]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lu J et al. (2024). Reconsidering Semaglutide Use for Chronic metabolic research models in research… [PMID: 39650923]
Laboratory literature summary: Reconsidering Semaglutide Use for Chronic metabolic research models in research subjects of Asian Descent: A Critical Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Du Y et al. (2024). A real-world disproportionality analysis of semaglutide: Post-marketing… [PMID: 38943656]
Laboratory literature summary: A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Song CE et al. (2024). Laboratory research record on GLP-1S [PMID: 38808720]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hamza A et al. (2020). ACTUALITIES IN ENDOCRINE PHARMACOLOGY: ADVANCES IN THE DEVELOPMENT OF ORAL… [PMID: 33363667]
Laboratory literature summary: ACTUALITIES IN ENDOCRINE PHARMACOLOGY: ADVANCES IN THE DEVELOPMENT OF ORAL FORMULATIONS FOR CALCITONIN AND SEMAGLUTIDE. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Dobriceanu RC et al. (2026). Laboratory research record on GLP-1S [PMID: 42510916]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Mao G et al. (2026). Letter: Non-Invasive Tests After Semaglutide in MASH as Disease-Activity Readouts… [PMID: 42402644]
Laboratory literature summary: Letter: Non-Invasive Tests After Semaglutide in MASH as Disease-Activity Readouts Rather Than Response Biomarkers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Abbasi J (2026). Laboratory research record on GLP-1S [PMID: 42313535]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Rossing P et al. (2026). Response to Comment on Rossing et al. Nuances in Interpretation: Assessing the… [PMID: 42160608]
Laboratory literature summary: Response to Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ma J et al. (2026). Impact of semaglutide on liver fibrosis score in people with HIV: findings from the… [PMID: 42138385]
Laboratory literature summary: Impact of semaglutide on liver fibrosis score in people with HIV: findings from the CNICS cohort. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sourij H et al. (2025). Improvement in Walking Distance With Semaglutide in Smokers With Peripheral Artery… [PMID: 41532935]
Laboratory literature summary: Improvement in Walking Distance With Semaglutide in Smokers With Peripheral Artery Disease: STRIDE Trial Subgroup Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sánchez-López D et al. (2026). FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's… [PMID: 41183609]
Laboratory literature summary: FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Serafini A et al. (2025). Laboratory research record on GLP-1S [PMID: 41176671]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Joly A et al. (2025). Semaglutide Exacerbates Stunting in Growth-Impaired Juvenile research models Mice via… [PMID: 41163813]
Laboratory literature summary: Semaglutide Exacerbates Stunting in Growth-Impaired Juvenile research models Mice via Reduced Energy Metabolism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stefano GB et al. (2025). Semaglutide and the pathogenesis of progressive neurodegenerative disease: the central… [PMID: 41047006]
Laboratory literature summary: Semaglutide and the pathogenesis of progressive neurodegenerative disease: the central role of mitochondria. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu L et al. (2024). Semaglutide May Ameliorate Fibrosis and Inhibit Epithelial-Mesenchymal Transition in… [PMID: 38892384]
Laboratory literature summary: Semaglutide May Ameliorate Fibrosis and Inhibit Epithelial-Mesenchymal Transition in Intrauterine Adhesion Models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cawthon CR et al. (2023). Chronic Semaglutide investigation in Rats Leads to Daily Excessive… [PMID: 37388574]
Laboratory literature summary: Chronic Semaglutide investigation in Rats Leads to Daily Excessive Concentration-Dependent Sucrose Intake. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Weghuber D et al. (2023). Semaglutide investigation for metabolic research models in teenagers: a plain language… [PMID: 36534451]
Laboratory literature summary: Semaglutide investigation for metabolic research models in teenagers: a plain language summary of the STEP TEENS research study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Singh AK et al. (2026). Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With… [PMID: 42420782]
Laboratory literature summary: Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full investigational Interchangeability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Schumacher E (2026). What the Scale Does Not Show: A research subjects's Reflection on Semaglutide,… [PMID: 42308137]
Laboratory literature summary: What the Scale Does Not Show: A research subjects's Reflection on Semaglutide, Strength, and the SMART Trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gasoyan H et al. (2026). Metabolic research models experimental regimens and Weight Changes in laboratory Practice After… [PMID: 41816857]
Laboratory literature summary: metabolic research models experimental regimens and Weight Changes in laboratory Practice After Discontinuation of Semaglutide or Tirzepatide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Asensio-Sánchez VM et al. (2026). Simultaneous bilateral NAION following initiation of high-exposure level semaglutide:… [PMID: 41796736]
Laboratory literature summary: Simultaneous bilateral NAION following initiation of high-exposure level semaglutide: a case report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Finsterer J (2026). Semaglutide can only be responsible for exercise intolerance and muscle wasting after… [PMID: 41326954]
Laboratory literature summary: Semaglutide can only be responsible for exercise intolerance and muscle wasting after all other causes have been carefully excluded. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Navaux E et al. (2025). Laboratory research record on GLP-1S [PMID: 41234778]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Petermann-Rocha F et al. (2026). How would the use of Semaglutide impact the Chilean population? An estimated analysis… [PMID: 41177925]
Laboratory literature summary: How would the use of Semaglutide impact the Chilean population? An estimated analysis following the SELECT trial approach. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wise J (2025). Body-composition research drugs: Semaglutide boosts heart health regardless of how… [PMID: 41130633]
Laboratory literature summary: body-composition research drugs: Semaglutide boosts heart health regardless of how much weight research subjects lose, study suggests. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wu J et al. (2025). GLP-1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis,… [PMID: 40815122]
Laboratory literature summary: GLP-1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis, Mitochondria Function and Ketosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sills ES et al. (2025). Semaglutide and research subjects reproduction: caution at the intersection of energy… [PMID: 40781307]
Laboratory literature summary: Semaglutide and research subjects reproduction: caution at the intersection of energy balance, ovarian function, and follicular development. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Haddy N et al. (2025). Laboratory research record on GLP-1S [PMID: 39930059]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Mansour NM et al. (2024). White analytical insight for sensitive fluorescent determination of semaglutide and… [PMID: 38508074]
Laboratory literature summary: White analytical insight for sensitive fluorescent determination of semaglutide and tirzepatide in pharmaceuticals and biological matrices. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nakova VV et al. (2023). Observed endpoints and laboratory profile of Empagliflozine and Semaglutide (Once… [PMID: 36987757]
Laboratory literature summary: observed endpoints and laboratory profile of Empagliflozine and Semaglutide (Once Weekly) in T2DM research subjects in Shtip. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Li R et al. (2022). Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via… [PMID: 36238196]
Laboratory literature summary: Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kane MP et al. (2021). Laboratory research record on GLP-1S [PMID: 33354706]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Karnan N et al. (2025). Evaluating the observed endpoints of ChatGPT vs. Google Gemini in Generating research… [PMID: 40351930]
Laboratory literature summary: Evaluating the observed endpoints of ChatGPT vs. Google Gemini in Generating research subjects Education Materials for GLP-1 Receptor…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sharma PK et al. (2026). Laboratory research record on GLP-1S [PMID: 41953358]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Yale JF et al. (2024). Laboratory research record on GLP-1S [PMID: 39118222]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Janić M et al. (2022). Laboratory research record on GLP-1S [PMID: 35258841]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Skandov MD et al. (2026). Laboratory research record on GLP-1S [PMID: 42420793]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Prasad S et al. (2026). Unexplained hypercapnia with normal pulmonary evaluation in a research subjects… [PMID: 42027588]
Laboratory literature summary: Unexplained hypercapnia with normal pulmonary evaluation in a research subjects receiving semaglutide: a analytical assessment challenge. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Müller-Wieland D et al. (2026). Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of… [PMID: 41969169]
Laboratory literature summary: Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Troshina EA et al. (2025). [A personalized, evidence-based approach to metabolic research models research… [PMID: 41640144]
Laboratory literature summary: [A personalized, evidence-based approach to metabolic research models research protocol using laboratory algorithms: semaglutide or…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kurinami N et al. (2025). Laboratory research record on GLP-1S [PMID: 41088952]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Singhal R et al. (2025). Laboratory research record on GLP-1S [PMID: 41054677]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Alkhouri N (2025). Recent Data From the ESSENCE Trial on Semaglutide in Metabolic Dysfunction-Associated… [PMID: 40115605]
Laboratory literature summary: Recent Data From the ESSENCE Trial on Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Cohen N et al. (2025). Laboratory research record on GLP-1S [PMID: 39732202]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Leslie A et al. (2024). Letter to the Editor Regarding "The Cardiovascular Conundrum: Navigating Semaglutide… [PMID: 39521577]
Laboratory literature summary: Letter to the Editor Regarding "The Cardiovascular Conundrum: Navigating Semaglutide Shortages and research subjects Well-being". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bikou A et al. (2024). A systematic review of the effect of semaglutide on lean mass: insights from… [PMID: 38629387]
Laboratory literature summary: A systematic review of the effect of semaglutide on lean mass: insights from laboratory trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Phizackerley D (2024). Semaglutide reduces the absolute risk of major cardiovascular events by 1.5 [PMID: 38224977]
Laboratory literature summary: Semaglutide reduces the absolute risk of major cardiovascular events by 1.5. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shabutdinova OR et al. (2023). [Semaglutide – effectiveness in body-composition research and observed outcomes in study models when used… [PMID: 37448249]
Laboratory literature summary: [Semaglutide – effectiveness in body-composition research and observed outcomes in study models when used according to studies by SUSTAIN, PIONEER, STEP]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sanz Segura P et al. (2022). Acute gastric dilation associated with the use of semaglutide, a GLP-1 analogue [PMID: 33545249]
Laboratory literature summary: Acute gastric dilation associated with the use of semaglutide, a GLP-1 analogue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tuchscherer RM et al. (2018). Laboratory research record on GLP-1S [PMID: 29932006]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Williams TC et al. (2017). Laboratory research record on GLP-1S [PMID: 28249136]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Marso SP et al. (2017). Laboratory research record on GLP-1S [PMID: 28249135]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Jiang T et al. (2026). Laboratory research record on GLP-1S [PMID: 42182879]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Dan K et al. (2026). Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic… [PMID: 41946762]
Laboratory literature summary: Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Decker SRR et al. (2026). Laboratory research record on GLP-1S [PMID: 41348220]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Wharton S et al. (2025). Laboratory research record on GLP-1S [PMID: 40934115]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Li W et al. (2025). Transdermal Semaglutide Administration in Mice: Reduces Body Weight by Suppressing… [PMID: 40427764]
Laboratory literature summary: Transdermal Semaglutide Administration in Mice: Reduces Body Weight by Suppressing feeding-behavior endpoints and Enhancing Metabolic Rate. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yan H et al. (2025). Laboratory research record on GLP-1S [PMID: 40402121]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Zhang J et al. (2025). Effects of semaglutide in research subjects with chronic ankle instability: evidence… [PMID: 40050929]
Laboratory literature summary: Effects of semaglutide in research subjects with chronic ankle instability: evidence from a prospective cohort. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Stanisavljevic I et al. (2024). Semaglutide decelerates the growth and progression of breast oncology research models… [PMID: 39536536]
Laboratory literature summary: Semaglutide decelerates the growth and progression of breast oncology research models by enhancing the acquired antitumor immunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Khan N (2024). How to 'drug' our way out of the metabolic research models crisis (or not): the… [PMID: 38664050]
Laboratory literature summary: How to 'drug' our way out of the metabolic research models crisis (or not): the roll-out of semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Duan X et al. (2024). Semaglutide alleviates gut microbiota dysbiosis induced by a high-fat diet [PMID: 38402930]
Laboratory literature summary: Semaglutide alleviates gut microbiota dysbiosis induced by a high-fat diet. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Shirakawa J et al. (2018). Laboratory research record on GLP-1S [PMID: 29955589]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Marso SP et al. (2016). Laboratory research record on GLP-1S [PMID: 27633186]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Cummings JL et al. (2026). Plain language summary: the evoke(+) studies of semaglutide for early… [PMID: 42159155]
Laboratory literature summary: Plain language summary: the evoke(+) studies of semaglutide for early neurodegeneration research models's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yoon JH et al. (2026). Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet [PMID: 42076092]
Laboratory literature summary: Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ali R et al. (2026). Semaglutide as a potential tool in pre-lung transplant body-composition research… [PMID: 41928866]
Laboratory literature summary: Semaglutide as a potential tool in pre-lung transplant body-composition research optimization. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Powell WJB et al. (2026). Comparison of Semaglutide and Lifestyle Counselling for body-composition research… [PMID: 41830068]
Laboratory literature summary: Comparison of Semaglutide and Lifestyle Counselling for body-composition research Using Multi-Site Electronic Health Records. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hitaka K et al. (2026). Observed endpoints of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide… [PMID: 41723268]
Laboratory literature summary: observed endpoints of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient metabolic research models and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Alsermani M et al. (2026). Deep Venous Thrombosis Within Two Weeks of Initiating Oral Semaglutide (Rybelsus): A… [PMID: 41646548]
Laboratory literature summary: Deep Venous Thrombosis Within Two Weeks of Initiating Oral Semaglutide (Rybelsus): A Case Report. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kelly A et al. (2026). Non-Arteritic Ischaemic Optic Neuropathy Associated with Semaglutide Use [PMID: 41589628]
Laboratory literature summary: Non-Arteritic Ischaemic Optic Neuropathy Associated with Semaglutide Use. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wen J et al. (2025). Association Between Semaglutide or Tirzepatide research protocol and Residual Gastric… [PMID: 41393547]
Laboratory literature summary: Association Between Semaglutide or Tirzepatide research protocol and Residual Gastric Content: A Potential Danger During Upper Endoscopy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Graabæk T et al. (2025). This Is My Decision': A Qualitative Study of Individuals' Perspectives on Use of… [PMID: 40521912]
Laboratory literature summary: This Is My Decision': A Qualitative Study of Individuals' Perspectives on Use of Semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kwaah PA et al. (2025). Laboratory research record on GLP-1S [PMID: 40466245]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Teixidor-Deulofeu J et al. (2025). Semaglutide effects on energy balance are mediated by Adcyap1(+) neurons in the dorsal… [PMID: 40409256]
Laboratory literature summary: Semaglutide effects on energy balance are mediated by Adcyap1(+) neurons in the dorsal vagal complex. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang JK et al. (2025). Semaglutide ameliorates metabolic disorders in offspring via regulation of oocyte ROS… [PMID: 39984623]
Laboratory literature summary: Semaglutide ameliorates metabolic disorders in offspring via regulation of oocyte ROS of pre-developmental research context metabolic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Davis TME (2025). Laboratory research record on GLP-1S [PMID: 39757501]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Snell-Bergeon JK et al. (2025). Laboratory research record on GLP-1S [PMID: 39745353]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Rizzo JF 3rd et al. (2024). Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic… [PMID: 39480403]
Laboratory literature summary: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy-Reply. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pinheiro MM et al. (2024). Laboratory research record on GLP-1S [PMID: 39072425]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Bensignor MO et al. (2024). Semaglutide for management of metabolic research models in adolescents: observed… [PMID: 38774967]
Laboratory literature summary: Semaglutide for management of metabolic research models in adolescents: observed endpoints, laboratory profile, and considerations for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sensi B et al. (2024). Letter to the Editor: Can semaglutide result in a tangible cardiovascular benefit in… [PMID: 38497771]
Laboratory literature summary: Letter to the Editor: Can semaglutide result in a tangible cardiovascular benefit in recipients of liver transplants?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Vernstrøm L et al. (2024). Laboratory research record on GLP-1S [PMID: 38240066]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Aranäs C et al. (2023). Semaglutide reduces alcohol intake and relapse-like drinking in research models and… [PMID: 37295046]
Laboratory literature summary: Semaglutide reduces alcohol intake and relapse-like drinking in research models and research models rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Aroda VR et al. (2023). Laboratory profile and tolerability of semaglutide across the SUSTAIN and PIONEER… [PMID: 36700417]
Laboratory literature summary: laboratory profile and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa laboratory trial programmes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Di Folco U et al. (2022). Laboratory research record on GLP-1S [PMID: 35842847]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Chang RS et al. (2022). Once-Weekly Semaglutide with Lifestyle Intervention Results in Clinically Significant… [PMID: 35230621]
Laboratory literature summary: Once-Weekly Semaglutide with Lifestyle Intervention Results in Clinically Significant body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Ipp E et al. (2017). Laboratory research record on GLP-1S [PMID: 28252263]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Sumbul HE et al. (2026). Laboratory research record on GLP-1S [PMID: 42278967]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Chen SC et al. (2026). Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists [PMID: 42420795]
Laboratory literature summary: Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Nguyen AT et al. (2026). Access Barriers and Variable Response to Semaglutide in Severe Adolescent metabolic… [PMID: 42369344]
Laboratory literature summary: Access Barriers and Variable Response to Semaglutide in Severe Adolescent metabolic research models: A Case Series. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gupta H et al. (2026). Laboratory research record on GLP-1S [PMID: 42257166]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Liu D et al. (2026). Role of the GAPDH-mediated glycolysis-senescence axis in osteoarthritis chondrocytes… [PMID: 42107588]
Laboratory literature summary: Role of the GAPDH-mediated glycolysis-senescence axis in osteoarthritis chondrocytes and its modulation by semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Salama M et al. (2026). Laboratory research record on GLP-1S [PMID: 41667135]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Bonaca MP et al. (2026). Laboratory research record on GLP-1S [PMID: 41654370]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Shil KK et al. (2025). Observed endpoints and laboratory profile of Tirzepatide and Semaglutide for metabolic… [PMID: 41523559]
Laboratory literature summary: observed endpoints and laboratory profile of Tirzepatide and Semaglutide for metabolic research models Management: A Real-World Comparison. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gulzar MAR (2025). Finerenone and semaglutide: Role in heart failure with reduced ejection fraction [PMID: 40496391]
Laboratory literature summary: Finerenone and semaglutide: Role in heart failure with reduced ejection fraction. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sørensen MS et al. (2025). Survey among adult users of semaglutide for body-composition research in Denmark: User… [PMID: 39905646]
Laboratory literature summary: Survey among adult users of semaglutide for body-composition research in Denmark: User characteristics, investigation expectations and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Rehman SU et al. (2024). Laboratory research record on GLP-1S [PMID: 39114239]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hansen MB et al. (2023). Laboratory research record on GLP-1S [PMID: 38604245]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Fernández-Ruiz I (2024). Laboratory research record on GLP-1S [PMID: 38036669]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Martínez-Montoro JI et al. (2024). Laboratory research record on GLP-1S [PMID: 37902577]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Chao AM et al. (2022). Laboratory research record on GLP-1S [PMID: 36601368]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Touzot M et al. (2022). Semaglutide for investigation of metabolic research models in hemodialysis research… [PMID: 36003674]
Laboratory literature summary: Semaglutide for investigation of metabolic research models in hemodialysis research subjects waiting for a kidney transplant: new hope?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Simó R et al. (2021). Laboratory research record on GLP-1S [PMID: 34440130]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Rajagopal S et al. (2021). Laboratory research record on GLP-1S [PMID: 34224258]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hearn EB et al. (2021). Laboratory research record on GLP-1S [PMID: 33627997]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Clements JN et al. (2021). Laboratory research record on GLP-1S [PMID: 33108617]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Morales J et al. (2020). Practical guidance for use of oral semaglutide in primary care: a narrative review [PMID: 32643514]
Laboratory literature summary: Practical guidance for use of oral semaglutide in primary care: a narrative review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Scheen AJ (2019). Laboratory research record on GLP-1S [PMID: 31486321]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lipscombe LL (2019). Laboratory research record on GLP-1S [PMID: 31426059]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Cosmi F et al. (2017). Laboratory research record on GLP-1S [PMID: 28252261]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Lappin JM et al. (2026). Body-composition research and gut microbial changes associated with semaglutide among… [PMID: 42372344]
Laboratory literature summary: body-composition research and gut microbial changes associated with semaglutide among people living with schizophrenia receiving…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Joma M et al. (2026). Semaglutide-Induced Ischemic Colitis in A Middle-Aged research models Without Vascular… [PMID: 42466220]
Laboratory literature summary: Semaglutide-Induced Ischemic Colitis in A Middle-Aged research models Without Vascular Risk Factors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang Y et al. (2026). Laboratory research record on GLP-1S [PMID: 42349668]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Chiang CH et al. (2026). Semaglutide and Risk of Pancreatic oncology research models: A Meta-Analysis of… [PMID: 42297743]
Laboratory literature summary: Semaglutide and Risk of Pancreatic oncology research models: A Meta-Analysis of Randomised Trials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Yammine L et al. (2026). Repurposing semaglutide as an adjunctive investigation for cocaine use disorder:… [PMID: 42161545]
Laboratory literature summary: Repurposing semaglutide as an adjunctive investigation for cocaine use disorder: protocol for a randomised controlled trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Medak KD et al. (2026). Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1… [PMID: 41774502]
Laboratory literature summary: Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Mouhammad ZA et al. (2026). Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via… [PMID: 41665299]
Laboratory literature summary: Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Do D et al. (2026). Laboratory research record on GLP-1S [PMID: 41576595]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Trocchio LL et al. (2026). Taking back control: The experience of adults using semaglutide and tirzepatide for… [PMID: 41399811]
Laboratory literature summary: Taking back control: The experience of adults using semaglutide and tirzepatide for metabolic research models investigation – A…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hawary OA et al. (2026). Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis [PMID: 41111129]
Laboratory literature summary: Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Bhagavathula AS (2025). Artificial intelligence and natural language processing of research subjects… [PMID: 40957545]
Laboratory literature summary: Artificial intelligence and natural language processing of research subjects narratives to evaluate semaglutide for body-composition…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Blümlinger M et al. (2025). Ileum targeted semaglutide delivery and pharmacokinetic study in an experimental… [PMID: 40850442]
Laboratory literature summary: Ileum targeted semaglutide delivery and pharmacokinetic study in an experimental porcine animal model via oesophagogastroduodenoscopic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Jara M et al. (2025). Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in… [PMID: 40691365]
Laboratory literature summary: Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Wulff BS et al. (2025). Laboratory research record on GLP-1S [PMID: 40629530]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Kishimori T et al. (2025). Laboratory research record on GLP-1S [PMID: 40594279]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Hsu AY et al. (2025). Laboratory research record on GLP-1S [PMID: 40146102]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Salem EA et al. (2025). Laboratory research record on GLP-1S [PMID: 40088335]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Wang Y et al. (2025). Regulation of nanoparticle exocytosis direction via receptors transfer: A novel… [PMID: 40064382]
Laboratory literature summary: Regulation of nanoparticle exocytosis direction via receptors transfer: A novel strategy to enhance investigational observed endpoints…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim SH et al. (2025). Peptide mapping analysis of synthetic semaglutide and liraglutide for generic… [PMID: 39847923]
Laboratory literature summary: Peptide mapping analysis of synthetic semaglutide and liraglutide for generic development of drugs originating from recombinant DNA…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Sandmeier M et al. (2025). Design of self-emulsifying oral delivery systems for semaglutide: reverse micelles… [PMID: 39427069]
Laboratory literature summary: Design of self-emulsifying oral delivery systems for semaglutide: reverse micelles versus hydrophobic ion pairs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Verma S et al. (2024). Laboratory research record on GLP-1S [PMID: 39217575]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Chaitoff A et al. (2024). Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of… [PMID: 39186788]
Laboratory literature summary: Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Tzoulis P et al. (2024). A Real-World Study of the Effectiveness and laboratory profile of Semaglutide for… [PMID: 38826889]
Laboratory literature summary: A Real-World Study of the Effectiveness and laboratory profile of Semaglutide for body-composition research. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Butuca A et al. (2024). An Assessment of Semaglutide laboratory profile Based on Real World Data: From… [PMID: 38791086]
Laboratory literature summary: An Assessment of Semaglutide laboratory profile Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Chen L et al. (2024). Semaglutide alleviates early brain injury following subarachnoid hemorrhage by… [PMID: 38715815]
Laboratory literature summary: Semaglutide alleviates early brain injury following subarachnoid hemorrhage by suppressing ferroptosis and neuroinflammation via SIRT1…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Borab ZM et al. (2024). Emerging Role of Semaglutide and GLP-1 Agonist Medications in Plastic Surgery: A Note… [PMID: 38507525]
Laboratory literature summary: Emerging Role of Semaglutide and GLP-1 Agonist Medications in Plastic Surgery: A Note of Caution. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Petri KCC et al. (2018). Laboratory research record on GLP-1S [PMID: 29748996]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Mantovani A et al. (2026). Semaglutide and Resmetirom in research subjects With Metabolic Dysfunction-Associated… [PMID: 42454420]
Laboratory literature summary: Semaglutide and Resmetirom in research subjects With Metabolic Dysfunction-Associated Steatohepatitis and Fibrosis: An Exploratory…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
La Vignera S et al. (2026). Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to… [PMID: 42449760]
Laboratory literature summary: Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to Semaglutide and Tirzepatide?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Hölscher C (2026). Semaglutide showed limited improvements in research subjects with neurodegeneration… [PMID: 42261705]
Laboratory literature summary: Semaglutide showed limited improvements in research subjects with neurodegeneration research models's disease: Revisiting the evoke and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Lakhani M et al. (2026). Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and… [PMID: 41807083]
Laboratory literature summary: Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Zhang Y et al. (2025). Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular… [PMID: 41293773]
Laboratory literature summary: Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular Vesicles. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
McGinnis T et al. (2026). Laboratory Effectiveness of Semaglutide for body-composition research in a Veterans… [PMID: 41233692]
Laboratory literature summary: laboratory Effectiveness of Semaglutide for body-composition research in a Veterans Affairs' Anti-metabolic research models…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Gaborit B (2025). Effect of Semaglutide on Epicardial Adipogenesis and hiPSC-Atrial Cardiomyocytes New… [PMID: 40992826]
Laboratory literature summary: Effect of Semaglutide on Epicardial Adipogenesis and hiPSC-Atrial Cardiomyocytes New Hope in Targeting Epicardial Adipose Tissue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kuo CC et al. (2025). Semaglutide versus other GLP-1 receptor agonists in research subjects with MASLD [PMID: 40536520]
Laboratory literature summary: Semaglutide versus other GLP-1 receptor agonists in research subjects with MASLD. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Odigwe C et al. (2025). Emerging role of GLP-1 agonists in cardio-metabolic research protocol – Focus on… [PMID: 40115122]
Laboratory literature summary: Emerging role of GLP-1 agonists in cardio-metabolic research protocol – Focus on Semaglutide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kushner RF et al. (2025). Laboratory research record on GLP-1S [PMID: 39948761]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Gajos G (2024). Laboratory research record on GLP-1S [PMID: 39287154]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Faust JS (2024). Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing laboratory Trials… [PMID: 39217571]
Laboratory literature summary: Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing laboratory Trials During Unexpected Outbreaks. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Kim GL et al. (2024). Laboratory research record on GLP-1S [PMID: 39065583]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Tomasello A et al. (2026). Laboratory research record on GLP-1S [PMID: 41567689]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Crisafulli S et al. (2026). Laboratory research record on GLP-1S [PMID: 41183330]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Deanfield J et al. (2025). Semaglutide and cardiovascular outcomes by baseline and changes in adiposity… [PMID: 41138739]
Laboratory literature summary: Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Atieh O et al. (2026). Laboratory research record on GLP-1S [PMID: 41098140]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Kargutkar S (2025). Increased body-composition research With the Combination of Levoketoconazole and… [PMID: 41048691]
Laboratory literature summary: Increased body-composition research With the Combination of Levoketoconazole and Semaglutide in a research subjects With Mild…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Pandey A et al. (2025). Frailty and Effects of Semaglutide in metabolic research models-Related HFpEF:… [PMID: 40956259]
Laboratory literature summary: Frailty and Effects of Semaglutide in metabolic research models-Related HFpEF: Findings From the STEP-HFpEF Program. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only
Joseph J (2025). Laboratory research record on GLP-1S [PMID: 40772215]
PubMed laboratory record discussing GLP-1S in a research context. Review the full methods and limitations on PubMed; research use only.
Xu Y et al. (2025). Design and Biosynthesis of Ornithine 8-Containing Semaglutide Variants with a Click… [PMID: 40305415]
Laboratory literature summary: Design and Biosynthesis of Ornithine 8-Containing Semaglutide Variants with a Click Chemistry-Modifiable Position 26. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight	.125 lbs
Dimensions	9 × 7 × .5 in
Size: No selection	2mg, 5mg, 10mg, 15mg, 20mg, 30mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is GLP-1 peptide?

GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring peptide involved in metabolic and glucose-related signaling. It is commonly studied in research laboratories for its role in endocrine and metabolic pathways.

What is GLP-1 used for in research?

GLP-1 is used in research laboratories to investigate metabolic signaling, insulin-related pathways, and peptide receptor activity. It is not approved for human use.

Is GLP-1S Peptide approved or intended for human use?

No. GLP-1 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is GLP-1S Peptide FDA-approved for medical or clinical use?

No. GLP-1 peptide products are not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is GLP-1 supplied?

GLP-1 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should GLP-1 be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for GLP-1?

GLP-1 is available in multiple vial sizes (e.g., 5000 IU, 10,000 IU).

Is GLP-1S Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is GLP-1 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit.

How can I verify GLP-1 purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency.

Frequently bought together

GLP-1S Peptide

Bacteriostatic Water (Bac Water) research-grade

Bacteriostatic Water (Bac Water) - 10ml

$16.00

	Product		Price
	Bacteriostatic Water (Bac Water) - 10ml
	GLP-1S Peptide

Frequently Asked Questions

What is GLP-1 peptide?

What is GLP-1 used for in research?

GLP-1 is used in research laboratories to investigate metabolic signaling, insulin-related pathways, and peptide receptor activity. It is not approved for human use.

Is GLP-1S Peptide approved or intended for human use?

No. GLP-1 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is GLP-1S Peptide FDA-approved for medical or clinical use?

No. GLP-1 peptide products are not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is GLP-1 supplied?

GLP-1 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should GLP-1 be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for GLP-1?

GLP-1 is available in multiple vial sizes (e.g., 5000 IU, 10,000 IU).

Is GLP-1S Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is GLP-1 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit.

How can I verify GLP-1 purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency.

SKU: GLP-1S Category: All Peptides Tags: dulaglutide, GLP-1, GLP-1 agonists, GLP-1 receptor agonists, GLP-1S, GLP1, GLP1 agonists, semaglutide Brand: Nationwide Peptides

Follow Us

Want to chat?

GLP-1S Peptide

Overview

Research Context for GLP-1S Peptide

Documented Attributes